CONMED Corporation (CNMD)
Largo, FL, US
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
| Target company | Date | Filing |
|---|---|---|
| Affiliates | 1998-04-15 | View |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.10% | -5.37% | -6.47% | -13.95% | -16.87% | -11.40% | -40.10% | -70.37% | -74.44% | -10.92% | +10,504.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 6 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 5 |
93.60
+124.5%
|
-
Revenue growth Medical - Devices: +11.2%+5.2% Q1'26: -0.7% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-64.6% Q1'26: +136.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+7.8% Q1'26: +3.3% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+10.3% ★ Q1'26: +8.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+5.1% ★ Q1'26: +4.2% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+0.1% Q1'26: -1.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×4.32× Q1'26: 5.62× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 4 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
694.74M
est: 669.92M (+3.7%)
|
713.72M
est: 646.98M (+10.3%)
|
725.08M
est: 665.90M (+8.9%)
|
767.14M
est: 760.01M (+0.9%)
|
756.76M
est: 751.84M (+0.7%)
|
734.47M
est: 716.47M (+2.5%)
|
719.17M
est: 717.77M (+0.2%)
|
763.52M
est: 762.93M (+0.1%)
|
796.39M
est: 786.03M (+1.3%)
|
859.63M
est: 845.70M (+1.6%)
|
955.10M
est: 955.20M (0.0%)
|
862.46M
est: 872.65M (-1.2%)
|
1.01B
est: 1.01B (-0.2%)
|
1.05B
est: 1.10B (-4.7%)
|
1.24B
est: 1.28B (-2.4%)
|
1.31B
est: 1.30B (+0.4%)
|
1.37B
est: 1.37B (+0.4%)
|
1.36B
1.36B – 1.37B
-0.5% YoY
|
1.44B
1.43B – 1.45B
+5.5% YoY
|
1.51B
1.51B – 1.51B
+5.4% YoY
|
| EBITDA |
66.52M
est: 58.24M (+14.2%)
|
94.58M
est: 80.23M (+17.9%)
|
47.06M
est: 42.25M (+11.4%)
|
111.83M
est: 110.65M (+1.1%)
|
104.11M
est: 102.42M (+1.7%)
|
98.52M
est: 96.04M (+2.6%)
|
95.05M
est: 102.34M (-7.1%)
|
90.04M
est: 89.49M (+0.6%)
|
105.48M
est: 101.43M (+4.0%)
|
133.11M
est: 125.17M (+6.3%)
|
146.25M
est: 137.98M (+6.0%)
|
118.28M
est: 138.48M (-14.6%)
|
179.33M
est: 153.66M (+16.7%)
|
7.80M
est: 66.67M (-88.3%)
|
192.48M
est: 253.09M (-24.0%)
|
272.18M
est: 258.27M (+5.4%)
|
193.47M
est: 271.44M (-28.7%)
|
270.07M
268.88M – 272.06M
-0.5% YoY
|
284.92M
282.95M – 286.90M
+5.5% YoY
|
300.20M
300.20M – 300.20M
+5.4% YoY
|
| EBIT |
25.24M
est: 26.20M (-3.7%)
|
57.01M
est: 50.61M (+12.6%)
|
8.27M
est: 10.68M (-22.5%)
|
65.21M
est: 64.62M (+0.9%)
|
56.25M
est: 55.54M (+1.3%)
|
52.79M
est: 52.05M (+1.4%)
|
51.18M
est: 55.16M (-7.2%)
|
34.73M
est: 37.53M (-7.4%)
|
46.94M
est: 45.39M (+3.4%)
|
71.31M
est: 67.04M (+6.4%)
|
73.93M
est: 74.85M (-1.2%)
|
45.66M
est: 45.30M (+0.8%)
|
108.59M
est: 95.23M (+14.0%)
|
-41.96M
est: 110.45M (-138.0%)
|
120.60M
est: 237.42M (-49.2%)
|
200.33M
est: 242.28M (-17.3%)
|
141.13M
est: 254.62M (-44.6%)
|
253.34M
252.23M – 255.21M
-0.5% YoY
|
267.27M
265.42M – 269.13M
+5.5% YoY
|
281.61M
281.61M – 281.61M
+5.4% YoY
|
| Net Income |
12.14M
est: 11.63M (+4.4%)
|
30.35M
est: 26.93M (+12.7%)
|
752.0K
est: 2.52M (-70.2%)
|
40.48M
est: 40.03M (+1.1%)
|
35.94M
est: 35.32M (+1.8%)
|
32.19M
est: 31.78M (+1.3%)
|
30.50M
est: 32.88M (-7.2%)
|
14.66M
est: 14.71M (-0.3%)
|
55.49M
est: 52.83M (+5.0%)
|
40.85M
est: 38.26M (+6.8%)
|
28.62M
est: 27.33M (+4.7%)
|
9.52M
est: -9.36M (+201.6%)
|
62.54M
est: 54.97M (+13.8%)
|
-80.58M
est: -111.81M (+27.9%)
|
64.46M
est: 99.95M (-35.5%)
|
132.42M
est: 125.11M (+5.8%)
|
47.06M
est: 140.18M (-66.4%)
|
136.07M
135.29M – 136.85M
-2.9% YoY
|
151.43M
148.49M – 154.38M
+11.3% YoY
|
171.56M
170.34M – 172.79M
+13.3% YoY
|
| SGA |
266.31M
est: 248.42M (+7.2%)
|
276.46M
est: 245.73M (+12.5%)
|
277.71M
est: 251.28M (+10.5%)
|
302.47M
est: 298.88M (+1.2%)
|
310.73M
est: 307.09M (+1.2%)
|
293.94M
est: 283.05M (+3.8%)
|
303.09M
est: 324.97M (-6.7%)
|
338.40M
est: 335.54M (+0.9%)
|
351.80M
est: 336.02M (+4.7%)
|
355.62M
est: 334.99M (+6.2%)
|
400.14M
est: 377.26M (+6.1%)
|
373.82M
est: 475.68M (-21.4%)
|
414.75M
est: 351.57M (+18.0%)
|
454.04M
est: 424.83M (+6.9%)
|
503.04M
est: 510.18M (-1.4%)
|
478.28M
est: 520.62M (-8.1%)
|
528.36M
est: 547.15M (-3.4%)
|
544.40M
542.01M – 548.41M
-0.5% YoY
|
574.34M
570.35M – 578.33M
+5.5% YoY
|
605.15M
605.15M – 605.15M
+5.4% YoY
|
| EPS |
0.42
est: 0.80 (-47.5%)
|
1.06
est: 1.06 (+0.0%)
|
0.03
est: 1.25 (-97.9%)
|
1.43
est: 1.77 (-19.2%)
|
1.30
est: 1.75 (-25.7%)
|
1.17
est: 1.81 (-35.4%)
|
1.10
est: 1.67 (-33.9%)
|
0.53
est: 1.86 (-71.5%)
|
1.99
est: 1.86 (+7.2%)
|
1.45
est: 2.17 (-33.2%)
|
1.01
est: 2.64 (-61.7%)
|
0.33
est: 2.10 (-84.3%)
|
2.14
est: 3.17 (-32.5%)
|
-2.68
est: 3.12 (-185.9%)
|
2.10
est: 3.20 (-34.5%)
|
4.29
est: 4.03 (+6.5%)
|
1.52
est: 4.50 (-66.2%)
|
4.37
4.34 – 4.39
-2.8% YoY
|
4.85
4.77 – 4.96
+10.8% YoY
|
5.50
5.47 – 5.55
+13.5% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-01 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-04-30 | JP Morgan | Neutral | Neutral | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 4.48M | 15.70% | 4.44M | — | 4.48M | — | HC | Delaware | 2021-02-05 | ↗ |
| 2 | The Vanguard Group - 23-1945930 | 3.00M | 10.50% | — | 63.2K | 2.92M | 86.3K | IA | Pennsylvania | 2021-02-10 | ↗ |
| 3 | (. | 2.34M | 8.43% | 2.26M | — | 2.34M | — | IA | Delaware Limited Partnership | 2016-02-09 | ↗ |
| 4 | SMALLCAP World Fund, Inc. | 2.14M | 7.70% | — | — | — | — | IV | Maryland | 2016-02-16 | ↗ |
| 5 | Abigail P. Johnson | 1.96M | 7.11% | — | — | 1.96M | — | IN | United States of America | 2015-02-13 | ↗ |
| 6 | Edward C. Johnson 3d | 1.96M | 7.11% | — | — | 1.96M | — | IN | United States of America | 2015-02-13 | ↗ |
| 7 | FMR LLC | 1.96M | 7.11% | 647.00 | — | 1.96M | — | HC | Delaware | 2015-02-13 | ↗ |
| 8 | JEREMY MINDICH | 1.69M | 6.10% | — | 1.69M | — | 10.00 | IN | USA | 2016-02-23 | ↗ |
| 9 | MATTHEW SIROVICH | 1.69M | 6.10% | — | 1.69M | — | 10.00 | IN | USA | 2016-02-23 | ↗ |
| 10 | SCOPIA CAPITAL MANAGEMENT LP | 1.69M | 6.10% | 1.69M | — | 1.69M | 10.00 | PN | DELAWARE | 2016-02-23 | ↗ |
| 11 | SCOPIA MANAGEMENT, INC. | 1.69M | 6.10% | 1.69M | — | 1.69M | 10.00 | CO | NEW YORK | 2016-02-23 | ↗ |
| 12 | SCOPIA CAPITAL GP LLC | 1.67M | 6.00% | 1.67M | — | 1.67M | 10.00 | OO | DELAWARE | 2016-02-23 | ↗ |
| 13 | 2 | 1.62M | 5.90% | — | 1.62M | — | 1.62M | HC, IN | United States | 2014-09-22 | ↗ |
| 14 | Andrew A. Ziegler | 739.3K | 2.70% | — | 677.0K | — | 739.3K | IN | Delaware | 2014-01-31 | ↗ |
| 15 | Artisan Investment Corporation | 739.3K | 2.70% | — | 677.0K | — | 739.3K | HC | Delaware | 2014-01-31 | ↗ |
| 16 | Artisan Investments GP LLC | 739.3K | 2.70% | — | 677.0K | — | 739.3K | HC | Delaware | 2014-01-31 | ↗ |
| 17 | Artisan Partners Asset Management Inc. | 739.3K | 2.70% | — | 677.0K | — | 739.3K | HC | Delaware | 2014-01-31 | ↗ |
| 18 | Artisan Partners Holdings LP | 739.3K | 2.70% | — | 677.0K | — | 739.3K | HC | Delaware | 2014-01-31 | ↗ |
| 19 | Artisan Partners Limited Partnership | 739.3K | 2.70% | — | 677.0K | — | 739.3K | IA | Delaware | 2014-01-31 | ↗ |
| 20 | Carlene M. Ziegler | 739.3K | 2.70% | — | 677.0K | — | 739.3K | IN | Delaware | 2014-01-31 | ↗ |
| 21 | ZFIC, Inc. | 739.3K | 2.70% | — | 677.0K | — | 739.3K | HC | Delaware | 2014-01-31 | ↗ |
| 22 | SCOPIA PX INTERNATIONAL MASTER FUND LP | 558.6K | 2.00% | 558.6K | — | 558.6K | 10.00 | PN | BERMUDA | 2016-02-23 | ↗ |
| 23 | 13-2700161 | 531.9K | 1.89% | 515.9K | — | 531.9K | — | IA | New York | 2019-02-01 | ↗ |
| 24 | Artisan Partners Funds, Inc. | 483.7K | 1.80% | — | 483.7K | — | 483.7K | IC | Delaware | 2014-01-31 | ↗ |
| 25 | SCOPIA PX LLC | 434.2K | 1.60% | 434.2K | — | 434.2K | 10.00 | OO | DELAWARE | 2016-02-23 | ↗ |
| 26 | SCOPIA WINDMILL FUND LP | 309.5K | 1.10% | 309.5K | — | 309.5K | 10.00 | PN | DELAWARE | 2016-02-23 | ↗ |
| 27 | SCOPIA HEALTH CARE INTERNATIONAL MASTER FUND LP | 245.0K | 1.00% | 245.0K | — | 245.0K | 10.00 | PN | BERMUDA | 2016-02-23 | ↗ |
| 28 | SCOPIA INTERNATIONAL MASTER FUND LP | 77.4K | 1.00% | 77.4K | — | 77.4K | 10.00 | PN | BERMUDA | 2016-02-23 | ↗ |
| 29 | SCOPIA HEALTH CARE LLC | 33.7K | 1.00% | 33.7K | — | 33.7K | 10.00 | OO | DELAWARE | 2016-02-23 | ↗ |
| 30 | SCOPIA PARTNERS LLC | 12.3K | 1.00% | 12.3K | — | 12.3K | 10.00 | OO | DELAWARE | 2016-02-23 | ↗ |
| 31 | JEROME J. LANDE | 4.0K | 1.00% | 4.0K | — | 4.0K | 10.00 | IN | USA | 2016-02-19 | ↗ |
| 32 | 95-1411037 | 13.00 | 7.20% | 2.19M | — | 2.19M | — | IA | Delaware | 2023-02-13 | ↗ |
| 33 | COPPERSMITH CAPITAL MANAGEMENT, LLC | — | 0.00% | — | — | — | 10.00 | OO | DELAWARE | 2016-02-19 | ↗ |
| 34 | CRAIG ROSENBLUM | — | 0.00% | — | — | — | 10.00 | IN | USA | 2016-02-19 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 104.1K +104.1K (+100.0%) | 4.23B +4.2B (+100.0%) | 0.34% +0.336 pp | 0.57% +0.573 pp | USD40.60 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 4.77M +130.3K (+2.8%) | 193.85M -24.6M (-11.2%) | 15.42% +0.412 pp | 0.00% -0.001 pp | USD71.07 -42.9% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 3.68M +73.5K (+2.0%) | 149.59M -20.2M (-11.9%) | 11.90% +0.230 pp | 0.00% 0.000 pp | USD92.53 -56.1% | 84 qtrs — |
| 4 | EARNEST PARTNERS LLC | 2.66M -135.8K (-4.9%) | 108.12M -23.5M (-17.9%) | 8.58% -0.463 pp | 0.46% -0.108 pp | USD86.70 -53.2% | 22 qtrs — |
| 5 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.59M -143.2K (-8.3%) | 64.62M -17.0M (-20.8%) | 5.14% -0.466 pp | 0.22% -0.059 pp | USD61.67 -34.2% | 5 qtrs — |
| 6 | STATE STREET CORP | 1.35M +83.7K (+6.6%) | 54.66M -5.0M (-8.3%) | 4.35% +0.268 pp | 0.00% 0.000 pp | USD62.52 -35.1% | 51 qtrs — |
| 7 | DIMENSIONAL FUND ADVISORS LP | 1.31M +16.0K (+1.2%) | 53.30M -7.7M (-12.6%) | 4.23% +0.040 pp | 0.01% -0.002 pp | USD48.88 -16.9% | 51 qtrs — |
| 8 | BANK OF AMERICA CORP /DE/ | 1.07M -234.9K (-18.1%) | 43.30M -17.9M (-29.3%) | 3.44% -0.761 pp | 0.00% -0.001 pp | USD79.93 -49.2% | 52 qtrs — |
| 9 | SEI INVESTMENTS CO | 981.0K +17.2K (+1.8%) | 39.83M -5.5M (-12.1%) | 3.16% +0.047 pp | 0.04% -0.009 pp | USD84.04 -51.7% | 32 qtrs — |
| 10 | CAPITAL RESEARCH GLOBAL INVESTORS | 925.4K -107.3K (-10.4%) | 37.57M -11.0M (-22.6%) | 2.98% -0.355 pp | 0.01% -0.002 pp | USD88.98 -54.4% | 51 qtrs — |
| 11 | COOKE & BIELER LP | 867.8K +163.5K (+23.2%) | 35.23M +2.1M (+6.4%) | 2.80% +0.520 pp | 0.37% +0.025 pp | USD67.55 -39.9% | 8 qtrs — |
| 12 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 866.8K -207.0K (-19.3%) | 35.19M -15.3M (-30.3%) | 2.80% -0.671 pp | 0.24% -0.092 pp | USD63.80 -36.4% | 5 qtrs — |
| 13 | INVENOMIC CAPITAL MANAGEMENT LP | 737.5K +317.5K (+75.6%) | 29.94M +10.2M (+51.6%) | 2.38% +1.025 pp | 1.39% +0.438 pp | USD44.26 -8.3% | 2 qtrs — |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 735.1K -2.1K (-0.3%) | 29.85M -4.8M (-13.9%) | 2.37% -0.008 pp | 0.00% 0.000 pp | USD78.08 -48.0% | 78 qtrs — |
| 15 | CITADEL ADVISORS LLC | 640.6K +585.4K (+1,061.2%) | 26.01M +23.4M (+902.4%) | 2.07% +1.890 pp | 0.00% +0.004 pp | USD41.31 -1.7% | 50 qtrs — |
| 16 | WASATCH ADVISORS LP | 574.9K -425.0K (-42.5%) | 23.34M -23.7M (-50.4%) | 1.85% -1.379 pp | 0.14% -0.114 pp | USD47.03 -13.7% | 2 qtrs — |
| 17 | GOLDMAN SACHS GROUP INC | 480.4K +264.8K (+122.9%) | 19.50M +9.4M (+92.4%) | 1.55% +0.855 pp | 0.00% +0.001 pp | USD47.16 -13.9% | 73 qtrs — |
| 18 | MORGAN STANLEY | 454.8K +161.9K (+55.3%) | 18.47M +4.7M (+34.0%) | 1.47% +0.522 pp | 0.00% +0.000 pp | USD69.61 -41.7% | 51 qtrs — |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 417.5K +11.1K (+2.7%) | 16.95M -2.2M (-11.3%) | 1.35% +0.032 pp | 0.00% 0.000 pp | USD63.93 -36.5% | 100 qtrs — |
| 20 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 416.4K +134.6K (+47.8%) | 16.87M +3.6M (+27.0%) | 1.34% +0.434 pp | 0.03% +0.006 pp | USD57.85 -29.8% | 17 qtrs — |
| 21 | NORTHERN TRUST CORP | 313.3K -12.5K (-3.8%) | 12.72M -2.6M (-17.0%) | 1.01% -0.041 pp | 0.00% 0.000 pp | USD50.51 -19.6% | 51 qtrs — |
| 22 | NEUBERGER BERMAN GROUP LLC | 290.1K -4.4K (-1.5%) | 11.79M -2.1M (-14.8%) | 0.93% -0.017 pp | 0.01% -0.001 pp | USD68.44 -40.7% | 5 qtrs — |
| 23 | BANK OF NEW YORK MELLON CORP | 284.9K +9.6K (+3.5%) | 11.57M -1.4M (-10.7%) | 0.92% +0.028 pp | 0.00% -0.001 pp | USD76.35 -46.8% | 66 qtrs — |
| 24 | JANE STREET GROUP, LLC | 276.9K +231.1K (+504.6%) | 11.24M +9.1M (+422.0%) | 0.89% +0.746 pp | 0.00% +0.001 pp | USD43.58 -6.8% | 24 qtrs — |
| 25 | TWO SIGMA INVESTMENTS, LP | 271.8K +107.4K (+65.3%) | 11.04M +3.3M (+42.7%) | 0.88% +0.347 pp | 0.02% +0.004 pp | USD47.72 -14.9% | 15 qtrs — |
| 26 | TRIBUTARY CAPITAL MANAGEMENT, LLC | 268.9K +61.1K (+29.4%) | 10.92M +1.1M (+11.7%) | 0.87% +0.197 pp | 1.08% +0.191 pp | USD45.57 -10.9% | 2 qtrs — |
| 27 | QUBE RESEARCH & TECHNOLOGIES LTD | 223.4K +118.5K (+113.0%) | 9.07M +4.1M (+83.9%) | 0.72% +0.383 pp | 0.01% +0.004 pp | USD46.83 -13.3% | 10 qtrs — |
| 28 | MARSHALL WACE, LLP | 222.4K +222.4K (+100.0%) | 9.03M +9.0M (+100.0%) | 0.72% +0.718 pp | 0.01% +0.008 pp | USD40.60 +0.0% | 1 qtrs NEW |
| 29 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 210.2K +101.1K (+92.6%) | 8.53M +3.4M (+66.3%) | 0.68% +0.326 pp | 0.03% +0.013 pp | USD55.03 -26.2% | 10 qtrs — |
| 30 | GLENMEDE TRUST CO NA | 203.5K +203.5K (+100.0%) | 8.26M +8.3M (+100.0%) | 0.66% +0.657 pp | 0.04% +0.039 pp | USD40.60 +0.0% | 1 qtrs NEW |
| 31 | MILLENNIUM MANAGEMENT LLC | 186.3K -10.2K (-5.2%) | 7.56M -1.7M (-18.1%) | 0.60% -0.033 pp | 0.00% -0.001 pp | USD47.03 -13.7% | 2 qtrs — |
| 32 | PRINCIPAL FINANCIAL GROUP INC | 184.8K +10.7K (+6.2%) | 7.50M -684.2K (-8.4%) | 0.60% +0.034 pp | 0.00% 0.000 pp | USD73.26 -44.6% | 81 qtrs — |
| 33 | INVESCO LTD. | 184.1K +42.4K (+29.9%) | 7.47M +810.3K (+12.2%) | 0.59% +0.137 pp | 0.00% +0.000 pp | USD65.91 -38.4% | 57 qtrs — |
| 34 | WELLS FARGO & COMPANY/MN | 170.8K -13.0K (-7.1%) | 6.94M -1.7M (-19.8%) | 0.55% -0.042 pp | 0.00% 0.000 pp | USD95.01 -57.3% | 57 qtrs — |
| 35 | AMERIPRISE FINANCIAL INC | 166.3K -4.4K (-2.6%) | 6.75M -1.3M (-15.9%) | 0.54% -0.014 pp | 0.00% 0.000 pp | USD106.72 -62.0% | 55 qtrs — |
| 36 | PRICE T ROWE ASSOCIATES INC /MD/ | 158.7K +4.2K (+2.7%) | 6.45M -825.0K (-11.3%) | 0.51% +0.013 pp | 0.00% 0.000 pp | USD126.30 -67.9% | 58 qtrs — |
| 37 | BNP PARIBAS ARBITRAGE, SNC | 155.7K +142.4K (+1,071.4%) | 6.32M +5.7M (+911.2%) | 0.50% +0.460 pp | 0.00% +0.003 pp | USD41.74 -2.7% | 51 qtrs — |
| 38 | LEGAL & GENERAL GROUP PLC | 147.4K +40.4K (+37.8%) | 5.99M +953.0K (+18.9%) | 0.48% +0.129 pp | 0.00% +0.000 pp | USD64.95 -37.5% | 46 qtrs — |
| 39 | RAYMOND JAMES FINANCIAL INC | 144.3K -28.6K (-16.5%) | 5.86M -2.3M (-27.9%) | 0.47% -0.093 pp | 0.00% -0.001 pp | USD65.88 -38.4% | 5 qtrs — |
| 40 | ENVESTNET ASSET MANAGEMENT INC | 143.6K -24.8K (-14.7%) | 5.83M -2.1M (-26.4%) | 0.46% -0.080 pp | 0.00% -0.001 pp | USD82.93 -51.0% | 51 qtrs — |
| 41 | PACER ADVISORS, INC. | 143.0K +143.0K (+100.0%) | 5.81M +5.8M (+100.0%) | 0.46% +0.462 pp | 0.01% +0.015 pp | USD40.60 +0.0% | 7 qtrs — |
| 42 | TREXQUANT INVESTMENT LP | 136.0K +136.0K (+100.0%) | 5.52M +5.5M (+100.0%) | 0.44% +0.439 pp | 0.05% +0.049 pp | USD40.60 +0.0% | 10 qtrs — |
| 43 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 131.9K +111.9K (+557.2%) | 5.36M +4.4M (+467.4%) | 0.43% +0.360 pp | 0.00% +0.003 pp | USD42.35 -4.1% | 3 qtrs — |
| 44 | POINT72 ASSET MANAGEMENT, L.P. | 131.0K +131.0K (+100.0%) | 5.32M +5.3M (+100.0%) | 0.42% +0.423 pp | 0.01% +0.006 pp | USD40.60 +0.0% | 1 qtrs NEW |
| 45 | BARCLAYS PLC | 120.2K -169.6K (-58.5%) | 4.88M -16.0M (-76.6%) | 0.39% -0.548 pp | 0.00% -0.004 pp | USD72.67 -44.1% | 39 qtrs — |
| 46 | D. E. SHAW & CO., INC. | 116.0K +49.0K (+73.2%) | 4.71M +1.6M (+49.6%) | 0.37% +0.158 pp | 0.00% +0.001 pp | USD52.90 -23.3% | 10 qtrs — |
| 47 | WEDGE CAPITAL MANAGEMENT L L P/NC | 114.4K +71.3K (+165.2%) | 4.65M +2.6M (+128.9%) | 0.37% +0.230 pp | 0.08% +0.049 pp | USD50.38 -19.4% | 6 qtrs — |
| 48 | TWO SIGMA ADVISERS, LP | 114.2K +60.6K (+113.1%) | 4.64M +2.1M (+83.9%) | 0.37% +0.196 pp | 0.01% +0.004 pp | USD49.50 -18.0% | 4 qtrs — |
| 49 | PANAGORA ASSET MANAGEMENT INC | 110.7K +27.2K (+32.6%) | 4.49M +567.6K (+14.5%) | 0.36% +0.087 pp | 0.02% +0.000 pp | USD45.45 -10.7% | 2 qtrs — |
| 50 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 107.3K -13.5K (-11.1%) | 4.36M -1.3M (-23.3%) | 0.35% -0.045 pp | 0.01% -0.006 pp | USD73.97 -45.1% | 58 qtrs — |
| 51 | NATIXIS ADVISORS, L.P. | 107.0K -67.9K (-38.8%) | 4.34M -3.9M (-47.2%) | 0.34% -0.220 pp | 0.01% -0.006 pp | USD65.69 -38.2% | 14 qtrs — |
| 52 | CRAWFORD INVESTMENT COUNSEL INC | 106.7K -217.3K (-67.1%) | 4.33M -10.9M (-71.6%) | 0.34% -0.702 pp | 0.07% -0.180 pp | USD83.92 -51.6% | 24 qtrs — |
| 53 | RHUMBLINE ADVISERS | 91.5K -5.4K (-5.6%) | 3.71M -842.1K (-18.5%) | 0.30% -0.018 pp | 0.00% -0.001 pp | USD64.52 -37.1% | 55 qtrs — |
| 54 | CONFLUENCE INVESTMENT MANAGEMENT LLC | 91.2K -30.4K (-25.0%) | 3.70M -2.0M (-35.2%) | 0.29% -0.098 pp | 0.06% -0.026 pp | USD70.21 -42.2% | 7 qtrs — |
| 55 | DANA INVESTMENT ADVISORS, INC. | 87.9K +25.3K (+40.5%) | 3.57M +625.6K (+21.2%) | 0.28% +0.081 pp | 0.10% +0.018 pp | USD52.42 -22.5% | 4 qtrs — |
| 56 | BANK OF MONTREAL /CAN/ | 85.1K +77.4K (+1,007.6%) | 3.45M +3.1M (+856.1%) | 0.27% +0.249 pp | 0.00% +0.001 pp | USD45.07 -9.9% | 51 qtrs — |
| 57 | TUDOR INVESTMENT CORP ET AL | 82.1K -42.9K (-34.3%) | 3.33M -2.5M (-43.3%) | 0.27% -0.139 pp | 0.01% -0.004 pp | USD48.71 -16.6% | 3 qtrs — |
| 58 | BESSEMER GROUP INC | 79.5K +79.2K (+26,937.1%) | 3.23M +3.2M (+21,413.3%) | 0.26% +0.255 pp | 0.01% +0.005 pp | USD40.83 -0.6% | 12 qtrs — |
| 59 | WINTON GROUP LTD | 78.9K +260.0 (+0.3%) | 3.20M -495.0K (-13.4%) | 0.25% +0.000 pp | 0.11% -0.028 pp | USD59.96 -32.3% | 4 qtrs — |
| 60 | ALLIANCEBERNSTEIN L.P. | 76.5K -1.0 (0.0%) | 3.10M -491.8K (-13.7%) | 0.25% 0.000 pp | 0.00% 0.000 pp | USD81.37 -50.1% | 61 qtrs — |
| 61 | UBS ASSET MANAGEMENT AMERICAS INC | 71.7K +3.7K (+5.5%) | 2.91M -284.8K (-8.9%) | 0.23% +0.012 pp | 0.00% 0.000 pp | USD76.96 -47.2% | 62 qtrs — |
| 62 | AMERICAN CENTURY COMPANIES INC | 71.5K +166.0 (+0.2%) | 2.90M -452.1K (-13.5%) | 0.23% 0.000 pp | 0.00% 0.000 pp | USD68.36 -40.6% | 8 qtrs — |
| 63 | VILLANOVA INVESTMENT MANAGEMENT CO LLC | 70.7K +11.9K (+20.3%) | 2.87M +105.6K (+3.8%) | 0.23% +0.038 pp | 2.02% +0.108 pp | USD45.95 -11.6% | 2 qtrs — |
| 64 | FIRST TRUST ADVISORS LP | 68.4K +18.3K (+36.4%) | 2.78M +419.4K (+17.8%) | 0.22% +0.058 pp | 0.00% +0.000 pp | USD57.67 -29.6% | 19 qtrs — |
| 65 | NORDEA INVESTMENT MANAGEMENT AB | 67.5K -9.4K (-12.2%) | 2.72M -824.3K (-23.2%) | 0.22% -0.031 pp | 0.00% -0.001 pp | USD66.71 -39.1% | 7 qtrs — |
| 66 | MORAN WEALTH MANAGEMENT, LLC | 65.8K -7.7K (-10.4%) | 2.67M -783.7K (-22.7%) | 0.21% -0.025 pp | 0.08% -0.022 pp | USD60.39 -32.8% | 4 qtrs — |
| 67 | NUVEEN, LLC | 65.4K -2.2K (-3.2%) | 2.66M -521.7K (-16.4%) | 0.21% -0.007 pp | 0.00% 0.000 pp | USD60.39 -32.8% | 4 qtrs — |
| 68 | JPMORGAN CHASE & CO | 61.2K -78.3K (-56.1%) | 2.48M -4.1M (-62.1%) | 0.20% -0.254 pp | 0.00% 0.000 pp | USD77.38 -47.5% | 51 qtrs — |
| 69 | SWISS NATIONAL BANK | 61.1K +1.1K (+1.8%) | 2.48M -341.1K (-12.1%) | 0.20% +0.003 pp | 0.00% 0.000 pp | USD62.68 -35.2% | 51 qtrs — |
| 70 | NEW YORK STATE COMMON RETIREMENT FUND | 60.2K -134.0K (-69.0%) | 2.44M -6.7M (-73.2%) | 0.19% -0.434 pp | 0.00% -0.009 pp | USD80.97 -49.9% | 82 qtrs — |
| 71 | EDGESTREAM PARTNERS, L.P. | 58.5K +58.5K (+100.0%) | 2.38M +2.4M (+100.0%) | 0.19% +0.189 pp | 0.07% +0.067 pp | USD40.60 +0.0% | 1 qtrs NEW |
| 72 | VICTORY CAPITAL MANAGEMENT INC | 58.4K +19.4K (+49.9%) | 2.37M +538.8K (+29.4%) | 0.19% +0.062 pp | 0.00% +0.000 pp | USD56.22 -27.8% | 43 qtrs — |
| 73 | GAMCO INVESTORS, INC. ET AL | 57.2K +— (+0.0%) | 2.32M -367.8K (-13.7%) | 0.18% -0.001 pp | 0.02% -0.004 pp | USD23.81 +70.5% | 64 qtrs — |
| 74 | COMERICA BANK | 56.3K +25.5K (+83.1%) | 2.28M +839.0K (+58.0%) | 0.18% +0.082 pp | 0.01% +0.004 pp | USD61.09 -33.5% | 10 qtrs — |
| 75 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 55.1K +54.7K (+16,735.2%) | 2.24M +2.2M (+14,800.0%) | 0.18% +0.176 pp | 0.00% +0.003 pp | USD40.67 -0.2% | 3 qtrs — |
| 76 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 52.6K -707.6K (-93.1%) | 2.13M -33.6M (-94.0%) | 0.17% -2.287 pp | 0.03% -0.519 pp | USD68.92 -41.1% | 9 qtrs — |
| 77 | CAMPBELL & CO INVESTMENT ADVISER LLC | 52.5K +52.5K (+100.0%) | 2.13M +2.1M (+100.0%) | 0.17% +0.169 pp | 0.10% +0.102 pp | USD40.60 +0.0% | 3 qtrs — |
| 78 | PENN CAPITAL MANAGEMENT COMPANY, LLC | 51.5K +51.5K (+100.0%) | 2.09M +2.1M (+100.0%) | 0.17% +0.166 pp | 0.17% +0.167 pp | USD40.60 +0.0% | 1 qtrs NEW |
| 79 | GOTHAM ASSET MANAGEMENT, LLC | 50.3K -312.0 (-0.6%) | 2.04M -338.4K (-14.2%) | 0.16% -0.001 pp | 0.01% -0.003 pp | USD51.47 -21.1% | 25 qtrs — |
| 80 | AQR CAPITAL MANAGEMENT LLC | 45.7K +29.8K (+187.7%) | 1.86M +1.1M (+148.4%) | 0.15% +0.096 pp | 0.00% +0.001 pp | USD49.75 -18.4% | 8 qtrs — |
| 81 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 45.6K +728.0 (+1.6%) | 1.85M -259.0K (-12.3%) | 0.15% +0.002 pp | 0.00% -0.001 pp | USD34.82 +16.6% | 51 qtrs — |
| 82 | UBS GROUP AG | 45.2K -92.1K (-67.1%) | 1.83M -4.6M (-71.6%) | 0.15% -0.298 pp | 0.00% -0.001 pp | USD55.20 -26.4% | 45 qtrs — |
| 83 | Y-INTERCEPT (HONG KONG) LTD | 43.4K +20.1K (+86.5%) | 1.76M +667.7K (+61.0%) | 0.14% +0.065 pp | 0.04% +0.013 pp | USD44.05 -7.8% | 2 qtrs — |
| 84 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 42.3K -4.0K (-8.6%) | 1.72M -460.1K (-21.1%) | 0.14% -0.013 pp | 0.04% -0.011 pp | USD47.03 -13.7% | 2 qtrs — |
| 85 | INTECH INVESTMENT MANAGEMENT LLC | 41.7K +18.5K (+79.7%) | 1.69M +601.4K (+55.1%) | 0.13% +0.059 pp | 0.02% +0.005 pp | USD54.08 -24.9% | 7 qtrs — |
| 86 | SEGALL BRYANT & HAMILL, LLC | 41.6K -88.0 (-0.2%) | 1.69M -271.4K (-13.9%) | 0.13% -0.001 pp | 0.02% -0.003 pp | USD50.28 -19.3% | 3 qtrs — |
| 87 | ALGERT GLOBAL LLC | 41.5K +12.3K (+42.3%) | 1.69M +313.0K (+22.8%) | 0.13% +0.040 pp | 0.03% +0.003 pp | USD45.12 -10.0% | 2 qtrs — |
| 88 | STIFEL FINANCIAL CORP | 40.9K +1.1K (+2.8%) | 1.66M -210.0K (-11.2%) | 0.13% +0.003 pp | 0.00% 0.000 pp | USD80.56 -49.6% | 22 qtrs — |
| 89 | PRUDENTIAL FINANCIAL INC | 39.1K +2.1K (+5.7%) | 1.59M -152.7K (-8.8%) | 0.13% +0.007 pp | 0.00% 0.000 pp | USD87.98 -53.9% | 85 qtrs — |
| 90 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 37.4K +37.4K (+100.0%) | 1.52M +1.5M (+100.0%) | 0.12% +0.121 pp | 0.02% +0.023 pp | USD40.60 +0.0% | 1 qtrs NEW |
| 91 | BRIDGE CITY CAPITAL, LLC | 35.5K -6.8K (-16.1%) | 1.44M -547.8K (-27.5%) | 0.11% -0.022 pp | 0.42% -0.108 pp | USD71.32 -43.1% | 6 qtrs — |
| 92 | TWINBEECH CAPITAL LP | 32.7K +21.0K (+179.0%) | 1.33M +776.3K (+140.8%) | 0.11% +0.068 pp | 0.09% +0.073 pp | USD44.72 -9.2% | 3 qtrs — |
| 93 | PDT PARTNERS, LLC | 32.7K -15.1K (-31.5%) | 1.33M -918.7K (-40.9%) | 0.11% -0.049 pp | 0.09% -0.056 pp | USD49.29 -17.6% | 13 qtrs — |
| 94 | OPPENHEIMER ASSET MANAGEMENT INC. | 31.2K -5.2K (-14.3%) | 1.27M -445.6K (-26.0%) | 0.10% -0.017 pp | 0.02% -0.003 pp | USD83.92 -51.6% | 22 qtrs — |
| 95 | ENGINEERS GATE MANAGER LP | 29.3K +20.6K (+238.4%) | 1.19M +781.7K (+192.1%) | 0.09% +0.067 pp | 0.01% +0.009 pp | USD45.51 -10.8% | 9 qtrs — |
| 96 | SQUAREPOINT OPS LLC | 28.7K +28.7K (+100.0%) | 1.17M +1.2M (+100.0%) | 0.09% +0.093 pp | 0.00% +0.001 pp | USD40.60 +0.0% | 11 qtrs — |
| 97 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 28.5K -29.0 (-0.1%) | 1.16M -184.6K (-13.8%) | 0.09% 0.000 pp | 0.00% 0.000 pp | USD45.10 -10.0% | 52 qtrs — |
| 98 | GABELLI FUNDS LLC | 28.2K +— (+0.0%) | 1.14M -181.3K (-13.7%) | 0.09% 0.000 pp | 0.01% -0.001 pp | USD23.81 +70.5% | 64 qtrs — |
| 99 | VOYA INVESTMENT MANAGEMENT LLC | 27.8K +442.0 (+1.6%) | 1.13M -157.9K (-12.3%) | 0.09% +0.001 pp | 0.00% 0.000 pp | USD104.48 -61.1% | 51 qtrs — |
| 100 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 27.7K +27.7K (+100.0%) | 1.13M +1.1M (+100.0%) | 0.09% +0.090 pp | 0.00% +0.001 pp | USD40.60 +0.0% | 1 qtrs NEW |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Beyer Pat | Officer | A-Award | A | RSUs (Restricted Stock Units) | 28,145 | 0.00 | — | 28,145 | D | ↗ |
| 2026-03-06 | Lalomia Brent | Officer | M-Exempt | A | Common Stock | 75 | 0.00 | — | 941 | D | ↗ |
| 2026-03-02 | Schabacker Matthew | Officer | A-Award | A | RSUs (Restricted Stock Units) | 9,827 | 0.00 | — | 9,827 | D | ↗ |
| 2026-03-02 | SHAGORY PETER K | Officer | A-Award | A | RSUs (Restricted Stock Units) | 9,282 | 0.00 | — | 9,282 | D | ↗ |
| 2026-03-02 | Pelletier Johonna Marie | Officer | A-Award | A | RSUs (Restricted Stock Units) | 5,896 | 0.00 | — | 5,896 | D | ↗ |
| 2026-03-02 | Moller Andrew James | Officer | A-Award | A | RSUs (Restricted Stock Units) | 5,896 | 0.00 | — | 5,896 | D | ↗ |
| 2026-03-02 | Lalomia Brent | Officer | A-Award | A | RSUs (Restricted Stock Units) | 9,554 | 0.00 | — | 9,554 | D | ↗ |
| 2026-03-02 | Foust Hollie K | Officer | A-Award | A | RSUs (Restricted Stock Units) | 10,919 | 0.00 | — | 10,919 | D | ↗ |
| 2026-03-02 | Ferrell John D. | Officer | A-Award | A | RSUs (Restricted Stock Units) | 9,282 | 0.00 | — | 9,282 | D | ↗ |
| 2026-03-02 | Beyer Pat | Officer | A-Award | A | RSUs (Restricted Stock Units) | 28,800 | 0.00 | — | 28,800 | D | ↗ |
| 2026-02-24 | Kaye Mark | Director | M-Exempt | D | RSUs (Restricted Stock Units) | 152 | 0.00 | — | 0 | D | ↗ |
| 2025-12-31 | Lalomia Brent | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-11-21 | Glaze Richard | Officer | S-Sale | D | Common Stock | 257 | 41.21 | 10.6K | 0 | D | ↗ |
| 2025-11-20 | Glaze Richard | Officer | M-Exempt | D | RSUs (Restricted Stock Units) | 375 | 0.00 | — | 750 | D | ↗ |
| 2025-11-06 | Garner Todd W | Officer | S-Sale | D | Common Stock | 3,500 | 43.00 | 150.5K | 1,836 | D | ↗ |
| 2025-11-04 | Foust Hollie K | Officer | M-Exempt | D | RSUs (Restricted Stock Units) | 4,000 | 0.00 | — | 4,000 | D | ↗ |
| 2025-10-31 | Garner Todd W | Officer | M-Exempt | D | RSUs (Restricted Stock Units) | 7,500 | 0.00 | — | 15,227 | D | ↗ |
| 2025-09-12 | Farkas Charles | Director | S-Sale | D | Common Stock | 897 | 53.51 | 48.0K | 14,859 | D | ↗ |
| 2025-09-08 | Kelderman Kim | Director | A-Award | A | RSUs (Restricted Stock Units) | 500 | 0.00 | — | 500 | D | ↗ |
| 2025-08-07 | Garner Todd W | Officer | S-Sale | D | Common Stock | 598 | 52.45 | 31.4K | 0 | D | ↗ |
| 2025-06-03 | Schwarzentraub Barbara J | Director | M-Exempt | D | RSUs (Restricted Stock Units) | 479 | 0.00 | — | 0 | D | ↗ |
| 2025-06-03 | Farkas Charles | Director | M-Exempt | D | RSUs (Restricted Stock Units) | 479 | 0.00 | — | 0 | D | ↗ |
| 2025-06-03 | Council LaVerne H | Director | M-Exempt | A | Common Stock | 479 | 0.00 | — | 4,048 | D | ↗ |
| 2025-06-03 | Concannon Brian | Director | M-Exempt | A | Common Stock | 479 | 0.00 | — | 10,116 | D | ↗ |
| 2025-06-03 | Bronson David M. | Director | M-Exempt | A | Common Stock | 479 | 0.00 | — | 17,241 | D | ↗ |
| 2025-06-03 | Aronson Martha Goldberg | Director | M-Exempt | A | Common Stock | 479 | 0.00 | — | 12,391 | D | ↗ |
| 2025-06-02 | Schwarzentraub Barbara J | Director | A-Award | A | RSUs (Restricted Stock Units) | 668 | 0.00 | — | 668 | D | ↗ |
| 2025-06-02 | Kaye Mark | Director | A-Award | A | RSUs (Restricted Stock Units) | 668 | 0.00 | — | 668 | D | ↗ |
| 2025-06-02 | Farkas Charles | Director | A-Award | A | RSUs (Restricted Stock Units) | 668 | 0.00 | — | 668 | D | ↗ |
| 2025-06-02 | Council LaVerne H | Director | A-Award | A | Options To Purchase Common Stock | 8,061 | 55.38 | 446.4K | 8,061 | D | ↗ |
| 2025-06-02 | Concannon Brian | Director | A-Award | A | RSUs (Restricted Stock Units) | 668 | 0.00 | — | 668 | D | ↗ |
| 2025-06-02 | Bronson David M. | Director | A-Award | A | RSUs (Restricted Stock Units) | 668 | 0.00 | — | 668 | D | ↗ |
| 2025-06-02 | Aronson Martha Goldberg | Director | A-Award | A | Options To Purchase Common Stock | 8,061 | 55.38 | 446.4K | 8,061 | D | ↗ |
| 2025-05-29 | Farkas Charles | Director | M-Exempt | A | Common Stock | 1,000 | 55.70 | 55.7K | 17,346 | D | ↗ |
| 2025-05-20 | Workman John L | Director | M-Exempt | D | RSUs (Restricted Stock Units) | 479 | 0.00 | — | 0 | D | ↗ |
| 2025-05-05 | Farkas Charles | Director | S-Sale | D | Common Stock | 4,000 | 56.94 | 227.8K | 16,346 | D | ↗ |
| 2025-04-28 | Schabacker Matthew | Officer | A-Award | A | Options To Purchase Common Stock | 31,675 | 50.84 | 1.61M | 31,675 | D | ↗ |
| 2025-03-31 | Garner Todd W | Officer | A-Award | A | Common Stock | 371 | 57.37 | 21.3K | 598 | D | ↗ |
| 2025-03-14 | SHAGORY PETER K | Officer | M-Exempt | D | SARs (Stock Appreciation Rights) | 4,500 | 55.42 | 249.4K | 0 | D | ↗ |
| 2025-03-07 | Lalomia Brent | Officer | F-InKind | D | Common Stock | 26 | 62.74 | 1.6K | 1,006 | D | ↗ |
| 2025-03-03 | SHAGORY PETER K | Officer | A-Award | A | Options To Purchase Common Stock | 26,127 | 58.33 | 1.52M | 26,127 | D | ↗ |
| 2025-03-03 | Pelletier Johonna Marie | Officer | A-Award | A | Options To Purchase Common Stock | 9,300 | 58.33 | 542.5K | 9,300 | D | ↗ |
| 2025-03-03 | Lalomia Brent | Officer | A-Award | A | Options To Purchase Common Stock | 26,895 | 58.33 | 1.57M | 26,895 | D | ↗ |
| 2025-03-03 | Glaze Richard | Officer | A-Award | A | Options To Purchase Common Stock | 11,750 | 58.33 | 685.4K | 11,750 | D | ↗ |
| 2025-03-03 | Garner Todd W | Officer | A-Award | A | Options To Purchase Common Stock | 61,475 | 58.33 | 3.59M | 61,475 | D | ↗ |
| 2025-03-03 | Foust Hollie K | Officer | A-Award | A | Options To Purchase Common Stock | 30,738 | 58.33 | 1.79M | 30,738 | D | ↗ |
| 2025-03-03 | Ferrell John D. | Officer | A-Award | A | Options To Purchase Common Stock | 21,516 | 58.33 | 1.26M | 21,516 | D | ↗ |
| 2025-03-03 | Epinette Stephan | Officer | A-Award | A | RSUs (Restricted Stock Units) | 17,144 | 0.00 | — | 17,144 | D | ↗ |
| 2025-03-03 | Clifford Edward A. | Officer | A-Award | A | Options To Purchase Common Stock | 26,127 | 58.33 | 1.52M | 26,127 | D | ↗ |
| 2025-02-24 | Kaye Mark | Director | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-02-24 | Epinette Stephan | Officer | — | — | RSUs (Restricted Stock Units) | 4,500 | 0.00 | — | 0 | D | ↗ |
| 2025-02-11 | Glaze Richard | Officer | S-Sale | D | Common Stock | 257 | 65.35 | 16.8K | 0 | D | ↗ |
| 2025-01-27 | Moller Andrew James | Officer | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-01-02 | Beyer Pat | Officer | A-Award | A | Options To Purchase Common Stock | 86,355 | 67.35 | 5.82M | 86,355 | D | ↗ |
| 2024-12-31 | Lalomia Brent | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-11-20 | Glaze Richard | Officer | M-Exempt | D | RSUs (Restricted Stock Units) | 375 | 0.00 | — | 1,125 | D | ↗ |
| 2024-11-07 | Hartman Curt R | Director / Officer | M-Exempt | A | Common Stock | 30,000 | 51.30 | 1.54M | 34,299 | D | ↗ |
| 2024-11-04 | Foust Hollie K | Officer | A-Award | A | RSUs (Restricted Stock Units) | 8,000 | 0.00 | — | 8,000 | D | ↗ |
| 2024-11-01 | Garner Todd W | Officer | A-Award | A | RSUs (Restricted Stock Units) | 22,727 | 0.00 | — | 22,727 | D | ↗ |
| 2024-09-05 | Farkas Charles | Director | M-Exempt | A | Common Stock | 1,000 | 39.64 | 39.6K | 20,880 | — | ↗ |
| 2024-08-01 | Clifford Edward A. | Officer | M-Exempt | D | Rsus (restricted Stock Units) | 500 | 0.00 | — | 1,500 | — | ↗ |
| 2024-07-01 | Staves Eric | Officer | — | D | Options To Purchase Common Stock | 1,000 | 78.76 | 78.8K | 0 | — | ↗ |
| 2024-06-14 | Peters Stanley W III | Officer | M-Exempt | A | Common Stock | 4,000 | 41.93 | 167.7K | 4,063 | — | ↗ |
| 2024-06-03 | Workman John L | Director | A-Award | A | Rsus (restricted Stock Units) | 479 | 0.00 | — | 479 | — | ↗ |
| 2024-06-03 | Schwarzentraub Barbara J | Director | A-Award | A | Options To Purchase Common Stock | 5,503 | 77.18 | 424.7K | 5,503 | — | ↗ |
| 2024-06-03 | Glaze Richard | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-03 | Farkas Charles | Director | A-Award | A | Rsus (restricted Stock Units) | 479 | 0.00 | — | 479 | — | ↗ |
| 2024-06-03 | Council LaVerne H | Director | A-Award | A | Rsus (restricted Stock Units) | 479 | 0.00 | — | 479 | — | ↗ |
| 2024-06-03 | CONCANNON BRIAN | Director | A-Award | A | Rsus (restricted Stock Units) | 479 | 0.00 | — | 479 | — | ↗ |
| 2024-06-03 | BRONSON DAVID M | Director | A-Award | A | Rsus (restricted Stock Units) | 479 | 0.00 | — | 479 | — | ↗ |
| 2024-06-03 | Aronson Martha Goldberg | Director | A-Award | A | Options To Purchase Common Stock | 5,503 | 77.18 | 424.7K | 5,503 | — | ↗ |
| 2024-05-31 | Workman John L | Director | M-Exempt | D | Rsus (restricted Stock Units) | 302 | 0.00 | — | 0 | — | ↗ |
| 2024-05-31 | Schwarzentraub Barbara J | Director | M-Exempt | A | Common Stock | 302 | 0.00 | — | 3,865 | — | ↗ |
| 2024-05-31 | Lande Jerome J. | Director | M-Exempt | D | Rsus (restricted Stock Units) | 302 | 0.00 | — | 0 | — | ↗ |
| 2024-05-31 | Farkas Charles | Director | M-Exempt | A | Common Stock | 302 | 0.00 | — | 19,880 | — | ↗ |
| 2024-05-31 | Council LaVerne H | Director | M-Exempt | D | Rsus (restricted Stock Units) | 302 | 0.00 | — | 0 | — | ↗ |
| 2024-05-31 | CONCANNON BRIAN | Director | M-Exempt | D | Rsus (restricted Stock Units) | 302 | 0.00 | — | 0 | — | ↗ |
| 2024-05-31 | BRONSON DAVID M | Director | M-Exempt | D | Rsus (restricted Stock Units) | 302 | 0.00 | — | 0 | — | ↗ |
| 2024-05-31 | Aronson Martha Goldberg | Director | M-Exempt | D | Rsus (restricted Stock Units) | 302 | 0.00 | — | 0 | — | ↗ |
| 2024-05-13 | BRONSON DAVID M | Director | P-Purchase | A | Common Stock | 1,350 | 72.09 | 97.3K | 16,460 | — | ↗ |
| 2024-05-08 | Schwarzentraub Barbara J | Director | P-Purchase | A | Common Stock | 1,442 | 69.26 | 99.9K | 1,442 | — | ↗ |
| 2024-05-06 | Aronson Martha Goldberg | Director | P-Purchase | A | Common Stock | 2,000 | 70.98 | 142.0K | 2,000 | — | ↗ |
| 2024-04-30 | Beyer Pat | Officer | P-Purchase | A | Common Stock | 3,000 | 68.30 | 204.9K | 10,807 | — | ↗ |
| 2024-04-24 | Beyer Pat | Officer | A-Award | A | Options To Purchase Common Stock | 20,060 | 70.01 | 1.40M | 20,060 | — | ↗ |
| 2024-03-28 | Garner Todd W | Officer | A-Award | A | Common Stock | 227 | 76.08 | 17.3K | 227 | — | ↗ |
| 2024-03-28 | Cohen Heather L | Officer | A-Award | A | Common Stock | 227 | 76.08 | 17.3K | 35,992 | — | ↗ |
| 2024-03-08 | Cohen Heather L | Officer | M-Exempt | D | Options To Purchase Common Stock | 27,500 | 59.96 | 1.65M | 0 | — | ↗ |
| 2024-03-07 | Lalomia Brent | Officer | M-Exempt | A | Common Stock | 75 | 0.00 | — | 983 | — | ↗ |
| 2024-03-01 | SHAGORY PETER K | Officer | A-Award | A | Options To Purchase Common Stock | 18,988 | 79.95 | 1.52M | 18,988 | — | ↗ |
| 2024-03-01 | Peters Stanley W III | Officer | A-Award | A | Options To Purchase Common Stock | 33,508 | 79.95 | 2.68M | 33,508 | — | ↗ |
| 2024-03-01 | Pelletier Johonna Marie | Officer | A-Award | A | Options To Purchase Common Stock | 8,000 | 79.95 | 639.6K | 8,000 | — | ↗ |
| 2024-03-01 | Lalomia Brent | Officer | A-Award | A | Options To Purchase Common Stock | 18,988 | 79.95 | 1.52M | 18,988 | — | ↗ |
| 2024-03-01 | Hartman Curt R | Director / Officer | A-Award | A | Options To Purchase Common Stock | 79,154 | 79.95 | 6.33M | 79,154 | — | ↗ |
| 2024-03-01 | Garner Todd W | Officer | A-Award | A | Options To Purchase Common Stock | 44,677 | 79.95 | 3.57M | 44,677 | — | ↗ |
| 2024-03-01 | Ferrell John D. | Officer | A-Award | A | Options To Purchase Common Stock | 11,250 | 79.95 | 899.4K | 11,250 | — | ↗ |
| 2024-03-01 | Cohen Heather L | Officer | A-Award | A | Options To Purchase Common Stock | 33,508 | 79.95 | 2.68M | 33,508 | — | ↗ |
| 2024-03-01 | Clifford Edward A. | Officer | A-Award | A | Options To Purchase Common Stock | 18,988 | 79.95 | 1.52M | 18,988 | — | ↗ |
| 2024-03-01 | Beyer Pat | Officer | A-Award | A | Options To Purchase Common Stock | 44,677 | 79.95 | 3.57M | 44,677 | — | ↗ |
| 2024-03-01 | Berge Terence M | Officer | A-Award | A | Options To Purchase Common Stock | 8,000 | 79.95 | 639.6K | 8,000 | — | ↗ |
| 2023-12-31 | SHAGORY PETER K | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-31 | Peters Stanley W III | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-31 | Lalomia Brent | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-31 | Cohen Heather L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-04 | Peters Stanley W III | Officer | M-Exempt | D | Options To Purchase Common Stock | 2,300 | 41.93 | 96.4K | 4,000 | — | ↗ |
| 2023-11-07 | Peters Stanley W III | Officer | M-Exempt | A | Common Stock | 1,200 | 41.93 | 50.3K | 1,263 | — | ↗ |
| 2023-09-13 | Peters Stanley W III | Officer | M-Exempt | A | Common Stock | 2,000 | 41.93 | 83.9K | 2,063 | — | ↗ |
| 2023-08-16 | Garner Todd W | Officer | S-Sale | D | Common Stock | 1,355 | 112.00 | 151.8K | 0 | — | ↗ |
| 2023-08-01 | Clifford Edward A. | Officer | — | D | Options To Purchase Common Stock | 8,000 | 118.20 | 945.6K | 0 | — | ↗ |
| 2023-06-30 | Cohen Heather L | Officer | A-Award | A | Common Stock | 16 | 129.10 | 2.1K | 29,370 | — | ↗ |
| 2023-06-17 | Lalomia Brent | Officer | M-Exempt | A | Common Stock | 250 | 0.00 | — | 979 | — | ↗ |
| 2023-06-15 | Hartman Curt R | Director / Officer | S-Sale | D | Common Stock | 1,000 | 136.00 | 136.0K | 4,299 | — | ↗ |
| 2023-06-09 | SHAGORY PETER K | Officer | M-Exempt | A | Common Stock | 4,500 | 55.42 | 249.4K | 6,361 | — | ↗ |
| 2023-06-08 | Peters Stanley W III | Officer | M-Exempt | A | Common Stock | 5,000 | 41.93 | 209.7K | 5,063 | — | ↗ |
| 2023-06-08 | Ferrell John D. | Officer | M-Exempt | A | Common Stock | 1,700 | 41.93 | 71.3K | 2,402 | — | ↗ |
| 2023-06-07 | CONCANNON BRIAN | Director | S-Sale | D | Common Stock | 812 | 129.01 | 104.8K | 9,335 | — | ↗ |
| 2023-06-01 | Workman John L | Director | M-Exempt | A | Common Stock | 335 | 0.00 | — | 20,110 | — | ↗ |
| 2023-06-01 | Schwarzentraub Barbara J | Director | M-Exempt | A | Common Stock | 335 | 0.00 | — | 3,563 | — | ↗ |
| 2023-06-01 | Lande Jerome J. | Director | M-Exempt | D | Rsus (restricted Stock Units) | 335 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | Ferrell John D. | Officer | — | D | Options To Purchase Common Stock | 9,000 | 122.55 | 1.10M | 0 | — | ↗ |
| 2023-06-01 | Farkas Charles | Director | A-Award | A | Options To Purchase Common Stock | 2,826 | 123.79 | 349.8K | 2,826 | — | ↗ |
| 2023-06-01 | Council LaVerne H | Director | M-Exempt | A | Common Stock | 335 | 0.00 | — | 3,267 | — | ↗ |
| 2023-06-01 | CONCANNON BRIAN | Director | M-Exempt | D | Rsus (restricted Stock Units) | 335 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | BRONSON DAVID M | Director | M-Exempt | A | Common Stock | 335 | 0.00 | — | 15,110 | — | ↗ |
| 2023-06-01 | Aronson Martha Goldberg | Director | M-Exempt | A | Common Stock | 335 | 0.00 | — | 11,610 | — | ↗ |
| 2023-05-22 | Peters Stanley W III | Officer | M-Exempt | D | Options To Purchase Common Stock | 1,500 | 41.93 | 62.9K | 14,500 | — | ↗ |
| 2023-05-18 | Peters Stanley W III | Officer | M-Exempt | D | Options To Purchase Common Stock | 1,500 | 41.93 | 62.9K | 16,000 | — | ↗ |
| 2023-05-01 | CONCANNON BRIAN | Director | S-Sale | D | Common Stock | 2,072 | 125.00 | 259.0K | 9,812 | — | ↗ |
| 2023-04-28 | SHAGORY PETER K | Officer | M-Exempt | A | Common Stock | 2,442 | 39.87 | 97.4K | 4,303 | — | ↗ |
| 2023-04-28 | Pelletier Johonna Marie | Officer | M-Exempt | D | Options To Purchase Common Stock | 2,000 | 41.93 | 83.9K | 0 | — | ↗ |
| 2023-04-28 | Jonas Daniel S | Officer | M-Exempt | A | Common Stock | 10,000 | 97.69 | 976.9K | 23,462 | — | ↗ |
| 2023-04-28 | Cohen Heather L | Officer | M-Exempt | A | Common Stock | 5,000 | 32.93 | 164.7K | 31,997 | — | ↗ |
| 2023-04-28 | Berge Terence M | Officer | M-Exempt | D | Options To Purchase Common Stock | 2,800 | 41.93 | 117.4K | 0 | — | ↗ |
| 2023-03-31 | Jonas Daniel S | Officer | A-Award | A | Common Stock | 40 | 98.67 | 3.9K | 14,088 | — | ↗ |
| 2023-03-31 | Garner Todd W | Officer | A-Award | A | Common Stock | 240 | 98.67 | 23.7K | 1,355 | — | ↗ |
| 2023-03-31 | Cohen Heather L | Officer | A-Award | A | Common Stock | 219 | 98.67 | 21.6K | 26,997 | — | ↗ |
| 2023-03-14 | Hartman Curt R | Director / Officer | S-Sale | D | Common Stock | 5,000 | 92.81 | 464.0K | 5,299 | — | ↗ |
| 2023-03-13 | Garner Todd W | Officer | M-Exempt | A | Common Stock | 30,000 | 50.61 | 1.52M | 31,115 | — | ↗ |
| 2023-03-07 | Lalomia Brent | Officer | M-Exempt | D | Rsus (restricted Stock Units) | 75 | 0.00 | — | 225 | — | ↗ |
| 2023-03-02 | Jonas Daniel S | Officer | S-Sale | D | Common Stock | 5,000 | 96.08 | 480.4K | 14,048 | — | ↗ |
| 2023-03-01 | SHAGORY PETER K | Officer | A-Award | A | Options To Purchase Common Stock | 15,159 | 96.16 | 1.46M | 15,159 | — | ↗ |
| 2023-03-01 | Peterson Jaclyn | Officer | M-Exempt | A | Common Stock | 250 | 0.00 | — | 829 | — | ↗ |
| 2023-03-01 | Peters Stanley W III | Officer | A-Award | A | Options To Purchase Common Stock | 20,843 | 96.16 | 2.00M | 20,843 | — | ↗ |
| 2023-03-01 | Pelletier Johonna Marie | Officer | A-Award | A | Options To Purchase Common Stock | 8,000 | 96.16 | 769.3K | 8,000 | — | ↗ |
| 2023-03-01 | Lalomia Brent | Officer | A-Award | A | Options To Purchase Common Stock | 12,317 | 96.16 | 1.18M | 12,317 | — | ↗ |
| 2023-03-01 | Jonas Daniel S | Officer | M-Exempt | D | Rsus (restricted Stock Units) | 2,500 | 0.00 | — | 0 | — | ↗ |
| 2023-03-01 | Hartman Curt R | Director / Officer | A-Award | A | Options To Purchase Common Stock | 67,141 | 96.16 | 6.46M | 67,141 | — | ↗ |
| 2023-03-01 | Garner Todd W | Officer | M-Exempt | A | Common Stock | 1,600 | 0.00 | — | 1,601 | — | ↗ |
| 2023-03-01 | Cohen Heather L | Officer | A-Award | A | Options To Purchase Common Stock | 18,948 | 96.16 | 1.82M | 18,948 | — | ↗ |
| 2023-03-01 | Beyer Pat | Officer | A-Award | A | Options To Purchase Common Stock | 32,212 | 96.16 | 3.10M | 32,212 | — | ↗ |
| 2023-03-01 | Berge Terence M | Officer | A-Award | A | Options To Purchase Common Stock | 8,000 | 96.16 | 769.3K | 8,000 | — | ↗ |
| 2022-12-31 | Peters Stanley W III | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-31 | Lalomia Brent | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-31 | KENNEDY JOHN JED | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-31 | Jonas Daniel S | Officer | — | D | Common Stock | 0 | 0.00 | — | 13,462 | — | ↗ |
| 2022-12-31 | Cohen Heather L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-12-30 | Jonas Daniel S | Officer | A-Award | A | Common Stock | 24 | 84.21 | 2.0K | 12,284 | — | ↗ |
| 2022-12-13 | Hartman Curt R | Officer | D-Return | D | Common Stock | 382 | 96.60 | 36.9K | 88,618 | — | ↗ |
| 2022-12-09 | Garner Todd W | Officer | M-Exempt | D | Options To Purchase Common Stock | 4,500 | 0.00 | — | 35,100 | — | ↗ |
| 2022-09-30 | Jonas Daniel S | Officer | A-Award | A | Common Stock | 26 | 76.16 | 2.0K | 12,260 | — | ↗ |
| 2022-08-12 | Peters Stanley W III | Officer | M-Exempt | D | Options To Purchase Common Stock | 7,500 | 0.00 | — | 17,500 | — | ↗ |
| 2022-08-10 | Cohen Heather L | Officer | M-Exempt | A | Common Stock | 5,000 | 32.93 | 164.7K | 29,625 | — | ↗ |
| 2022-06-30 | Lalomia Brent | Officer | L-Small | A | Common Stock | 1 | 97.69 | 72.00 | 679 | — | ↗ |
| 2022-06-30 | Jonas Daniel S | Officer | A-Award | A | Common Stock | 22 | 90.97 | 2.0K | 12,234 | — | ↗ |
| 2022-06-30 | Garner Todd W | Officer | A-Award | A | Common Stock | 1 | 90.97 | 90.97 | 1 | — | ↗ |
| 2022-06-30 | Cohen Heather L | Officer | A-Award | A | Common Stock | 1 | 90.97 | 90.97 | 24,625 | — | ↗ |
| 2022-06-17 | Lalomia Brent | Officer | M-Exempt | D | Rsus (restricted Stock Units) | 250 | 0.00 | — | 250 | — | ↗ |
| 2022-06-13 | Garner Todd W | Officer | S-Sale | D | Common Stock | 2,662 | 99.79 | 265.6K | 0 | — | ↗ |
| 2022-06-01 | Workman John L | Director | M-Exempt | A | Common Stock | 812 | 0.00 | — | 19,775 | — | ↗ |
| 2022-06-01 | TRYNISKI MARK E | Director | M-Exempt | D | Rsus (restricted Stock Units) | 812 | 0.00 | — | 0 | — | ↗ |
| 2022-06-01 | Schwarzentraub Barbara J | Director | A-Award | A | Options To Purchase Common Stock | 3,453 | 0.00 | — | 3,453 | — | ↗ |
| 2022-06-01 | Lande Jerome J. | Director | M-Exempt | A | Common Stock | 812 | 0.00 | — | 3,219 | — | ↗ |
| 2022-06-01 | Farkas Charles | Director | A-Award | A | Rsus (restricted Stock Units) | 335 | 0.00 | — | 335 | — | ↗ |
| 2022-06-01 | Council LaVerne H | Director | A-Award | A | Options To Purchase Common Stock | 3,453 | 111.79 | 386.0K | 3,453 | — | ↗ |
| 2022-06-01 | CONCANNON BRIAN | Director | A-Award | A | Rsus (restricted Stock Units) | 335 | 0.00 | — | 335 | — | ↗ |
| 2022-06-01 | BRONSON DAVID M | Director | M-Exempt | A | Common Stock | 812 | 0.00 | — | 14,775 | — | ↗ |
| 2022-06-01 | Aronson Martha Goldberg | Director | A-Award | A | Options To Purchase Common Stock | 3,453 | 0.00 | — | 3,453 | — | ↗ |
| 2022-05-13 | Lande Jerome J. | Director | S-Sale | D | Common Stock | 1,521 | 117.00 | 178.0K | 2,407 | — | ↗ |
| 2022-05-10 | Peterson Jaclyn | Officer | M-Exempt | D | Rsus (restricted Stock Units) | 500 | 0.00 | — | 1,500 | — | ↗ |
| 2022-04-01 | Lalomia Brent | Officer | — | D | Rsus (restricted Stock Units) | 300 | 0.00 | — | 0 | — | ↗ |
| 2022-03-31 | Peterson Jaclyn | Officer | A-Award | A | Common Stock | 169 | 141.12 | 23.8K | 233 | — | ↗ |
| 2022-03-31 | Jonas Daniel S | Officer | A-Award | A | Common Stock | 45 | 141.12 | 6.4K | 12,212 | — | ↗ |
| 2022-03-31 | Garner Todd W | Officer | A-Award | A | Common Stock | 168 | 141.12 | 23.7K | 2,662 | — | ↗ |
| 2022-03-31 | Cohen Heather L | Officer | A-Award | A | Common Stock | 168 | 141.12 | 23.7K | 24,624 | — | ↗ |
| 2022-03-15 | Hartman Curt R | Officer | F-InKind | D | Common Stock | 8,650 | 138.85 | 1.20M | 13,799 | — | ↗ |
| 2022-03-04 | Jonas Daniel S | Officer | M-Exempt | D | Options To Purchase Common Stock | 11,157 | 78.76 | 878.7K | 10,000 | — | ↗ |
| 2022-03-03 | KENNEDY JOHN JED | Officer | M-Exempt | D | Options To Purchase Common Stock | 5,092 | 59.96 | 305.3K | 5,400 | — | ↗ |
| 2022-03-02 | KENNEDY JOHN JED | Officer | M-Exempt | A | Common Stock | 5,000 | 41.93 | 209.7K | 14,855 | — | ↗ |
| 2022-03-01 | SHAGORY PETER K | Officer | A-Award | A | Options To Purchase Common Stock | 20,000 | 144.55 | 2.89M | 20,000 | — | ↗ |
| 2022-03-01 | Peterson Jaclyn | Officer | A-Award | A | Options To Purchase Common Stock | 16,000 | 144.55 | 2.31M | 16,000 | — | ↗ |
| 2022-03-01 | Peters Stanley W III | Officer | A-Award | A | Options To Purchase Common Stock | 35,000 | 144.55 | 5.06M | 35,000 | — | ↗ |
| 2022-03-01 | Pelletier Johonna Marie | Officer | A-Award | A | Options To Purchase Common Stock | 10,000 | 144.55 | 1.45M | 10,000 | — | ↗ |
| 2022-03-01 | KENNEDY JOHN JED | Officer | M-Exempt | D | Rsus (restricted Stock Units) | 1,250 | 0.00 | — | 1,250 | — | ↗ |
| 2022-03-01 | Jonas Daniel S | Officer | A-Award | A | Rsus (restricted Stock Units) | 2,500 | 0.00 | — | 2,500 | — | ↗ |
| 2022-03-01 | Hartman Curt R | Director / Officer | A-Award | A | Options To Purchase Common Stock | 125,000 | 144.55 | 18.07M | 125,000 | — | ↗ |
| 2022-03-01 | Garner Todd W | Officer | M-Exempt | D | Rsus (restricted Stock Units) | 1,600 | 0.00 | — | 1,600 | — | ↗ |
| 2022-03-01 | Cohen Heather L | Officer | A-Award | A | Options To Purchase Common Stock | 33,000 | 144.55 | 4.77M | 33,000 | — | ↗ |
| 2022-03-01 | Beyer Pat | Officer | A-Award | A | Options To Purchase Common Stock | 55,000 | 144.55 | 7.95M | 55,000 | — | ↗ |
| 2022-03-01 | Berge Terence M | Officer | A-Award | A | Options To Purchase Common Stock | 10,000 | 144.55 | 1.45M | 10,000 | — | ↗ |
| 2022-02-25 | Peters Stanley W III | Officer | M-Exempt | D | Options To Purchase Common Stock | 2,700 | 39.87 | 107.6K | 0 | — | ↗ |
| 2022-02-25 | Jonas Daniel S | Officer | S-Sale | D | Common Stock | 500 | 150.03 | 75.0K | 12,167 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Patrick J. Beyer President and Chief Executive Officer | 891.1K | — | 2.50M | 2.50M | 1.13M | 614.4K | 7.63M | 65.49% | ↗ |
| 2 | 2025 | Todd W. Garner Executive Vice President, Finance and Chief Financial Officer | 610.0K | — | 500.1K | 1.50M | 659.4K | 28.0K | 3.30M | 60.66% | ↗ |
| 3 | 2025 | Hollie Foust Executive Vice President, General Counsel and Corporate Secretary | 457.5K | — | 250.0K | 750.0K | 378.2K | 7.1K | 1.84M | 54.27% | ↗ |
| 4 | 2025 | Brent Lalomia Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations | 424.5K | 50.0K | 218.7K | 656.2K | 276.1K | 37.2K | 1.66M | 52.62% | ↗ |
| 5 | 2025 | Peter K. Shagory Executive Vice President, Strategy and Corporate Development | 386.0K | — | 212.5K | 637.5K | 320.5K | 7.3K | 1.56M | 54.36% | ↗ |
| 6 | 2024 | Curt R. Hartman Chair, President & Chief Executive Officer | 966.2K | — | 2.66M | 2.66M | 882.6K | 203.0K | 7.37M | 72.15% | ↗ |
| 7 | 2024 | Todd W. Garner Executive Vice President, Finance and Chief Financial Officer | 565.8K | — | 2.10M | 1.50M | 397.9K | 79.3K | 4.64M | 77.54% | ↗ |
| 8 | 2024 | Patrick J. Beyer Chief Operating Officer | 584.8K | — | 699.9K | 2.10M | 398.3K | 517.2K | 4.30M | 65.11% | ↗ |
| 9 | 2024 | Patrick J. Beyer President and Chief Executive Officer | 584.8K | — | 699.9K | 2.10M | 398.3K | 517.2K | 4.30M | 65.11% | ↗ |
| 10 | 2024 | Stanley W. (Bill) Peters President, Advanced Surgical & Advanced Endoscopic Technologies | 316.2K | — | 375.0K | 1.12M | — | 770.9K | 2.59M | 57.98% | ↗ |
| 11 | 2024 | Heather Cohen Executive Vice President & Chief Human Resources and Legal Officer & Secretary | 596.4K | — | 375.0K | 1.12M | 69.4K | 85.1K | 2.25M | 66.64% | ↗ |
| 12 | 2024 | Peter K. Shagory Executive Vice President, Strategy and Corporate Development | 368.7K | — | 212.6K | 637.4K | 198.2K | 7.1K | 1.42M | 59.69% | ↗ |
| 13 | 2024 | Peter Shagory EVP Strategy & Corp Development | 368.7K | — | 212.6K | 637.4K | 198.2K | 7.1K | 1.42M | 59.69% | ↗ |
| 14 | 2024 | Brent Lalomia Vice President, Quality Assurance, Regulatory Affairs, Customer Experience, and Logistics | 317.7K | — | 212.6K | 637.4K | 175.1K | 49.6K | 1.39M | 61.05% | ↗ |
| 15 | 2024 | Brent Lalomia Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations | 317.7K | — | 212.6K | 637.4K | 175.1K | 49.6K | 1.39M | 61.05% | ↗ |
| 16 | 2023 | Curt R. Hartman Chair, President & Chief Executive Officer | 950.0K | — | 2.66M | 2.66M | 1.40M | 103.1K | 7.76M | 68.45% | ↗ |
| 17 | 2023 | Curt R. Hartman – Chair, President & Chief Executive Officer | 950.0K | — | 2.66M | 2.66M | 1.40M | 103.1K | 7.76M | 68.45% | ↗ |
| 18 | 2023 | Patrick J. Beyer – President, International & Global Orthopedics | 548.9K | — | 425.1K | 1.27M | 505.3K | 545.1K | 3.30M | 51.53% | ↗ |
| 19 | 2023 | Patrick J. Beyer President and Chief Executive Officer | 548.9K | — | 425.1K | 1.27M | 505.3K | 545.1K | 3.30M | 51.53% | ↗ |
| 20 | 2023 | Patrick J. Beyer Chief Operating Officer | 548.9K | — | 425.1K | 1.27M | 505.3K | 545.1K | 3.30M | 51.53% | ↗ |
| 21 | 2023 | Todd W. Garner – Executive Vice President, Finance and Chief Financial Officer | 539.0K | — | 425.1K | 1.27M | 579.1K | 53.8K | 2.87M | 59.20% | ↗ |
| 22 | 2023 | Todd W. Garner Executive Vice President, Finance and Chief Financial Officer | 539.0K | — | 425.1K | 1.27M | 579.1K | 53.8K | 2.87M | 59.20% | ↗ |
| 23 | 2023 | Stanley W. (Bill) Peters President, Advanced Surgical & Advanced Endoscopic Technologies | 451.7K | — | 275.0K | 825.0K | 389.3K | 56.0K | 2.00M | 55.08% | ↗ |
| 24 | 2023 | Stanley W. (Bill) Peters – President, Advanced Surgical & Advanced Endoscopic Technologies | 451.7K | — | 275.0K | 825.0K | 389.3K | 56.0K | 2.00M | 55.08% | ↗ |
| 25 | 2023 | Heather L. Cohen - Executive Vice President & Chief Human Resources and Legal Officer & Secretary | 420.0K | — | 249.9K | 750.0K | 361.4K | 45.5K | 1.83M | 54.74% | ↗ |
| 26 | 2023 | Heather Cohen Executive Vice President & Chief Human Resources and Legal Officer & Secretary | 420.0K | — | 249.9K | 750.0K | 361.4K | 45.5K | 1.83M | 54.74% | ↗ |
| 27 | 2022 | Curt R. Hartman – Chair, President & Chief Executive Officer | 946.1K | — | — | 6.34M | 425.1K | 124.3K | 7.84M | 80.91% | ↗ |
| 28 | 2022 | Curt R. Hartman – Chair of the Board, President & Chief Executive Officer | 946.1K | — | — | 6.34M | 425.1K | 124.3K | 7.84M | 80.91% | ↗ |
| 29 | 2022 | Curt R. Hartman Chair, President & Chief Executive Officer | 946.1K | — | — | 6.34M | 425.1K | 124.3K | 7.84M | 80.91% | ↗ |
| 30 | 2022 | Patrick J. Beyer – President, CONMED International & Global Orthopedics | 501.5K | 58.8K | — | 2.79M | 165.3K | 497.6K | 4.01M | 69.52% | ↗ |
| 31 | 2022 | Patrick J. Beyer Chief Operating Officer | 501.5K | 58.8K | — | 2.79M | 165.3K | 497.6K | 4.01M | 69.52% | ↗ |
| 32 | 2022 | Patrick J. Beyer – President, International & Global Orthopedics | 501.5K | 58.8K | — | 2.79M | 165.3K | 497.6K | 4.01M | 69.52% | ↗ |
| 33 | 2022 | Todd W. Garner – Executive Vice President and Chief Financial Officer | 521.7K | 30.0K | — | 2.79M | 171.1K | 60.7K | 3.57M | 78.07% | ↗ |
| 34 | 2022 | Todd W. Garner Executive Vice President, Finance and Chief Financial Officer | 521.7K | 30.0K | — | 2.79M | 171.1K | 60.7K | 3.57M | 78.07% | ↗ |
| 35 | 2022 | Todd W. Garner – Executive Vice President, Finance and Chief Financial Officer | 521.7K | 30.0K | — | 2.79M | 171.1K | 60.7K | 3.57M | 78.07% | ↗ |
| 36 | 2022 | Stanley W. (Bill) Peters President, Advanced Surgical & Advanced Endoscopic Technologies | 434.0K | 25.0K | — | 1.78M | 124.2K | 64.9K | 2.42M | 73.25% | ↗ |
| 37 | 2022 | Stanley W. (Bill) Peters – Vice President & General Manager, U.S. Advanced Surgical | 434.0K | 25.0K | — | 1.78M | 124.2K | 64.9K | 2.42M | 73.25% | ↗ |
| 38 | 2022 | Stanley W. (Bill) Peters – President, Advanced Surgical & Advanced Endoscopic Technologies | 434.0K | 25.0K | — | 1.78M | 124.2K | 64.9K | 2.42M | 73.25% | ↗ |
| 39 | 2022 | Heather L. Cohen – Executive Vice President & Chief Human Resources and Legal Officer | 408.8K | — | — | 1.67M | 111.1K | 41.2K | 2.23M | 74.90% | ↗ |
| 40 | 2022 | Heather L. Cohen - Executive Vice President & Chief Human Resources and Legal Officer & Secretary | 408.8K | — | — | 1.67M | 111.1K | 41.2K | 2.23M | 74.90% | ↗ |
| 41 | 2022 | Heather Cohen Executive Vice President & Chief Human Resources and Legal Officer & Secretary | 408.8K | — | — | 1.67M | 111.1K | 41.2K | 2.23M | 74.90% | ↗ |
| 42 | 2021 | Curt R. Hartman – Chair of the Board, President & Chief Executive Officer | 918.1K | — | — | 7.38M | 957.9K | 122.5K | 9.37M | 78.68% | ↗ |
| 43 | 2021 | Curt R. Hartman – Chair, President & Chief Executive Officer | 918.1K | — | — | 7.38M | 957.9K | 122.5K | 9.37M | 78.68% | ↗ |
| 44 | 2021 | Patrick J. Beyer – President, International & Global Orthopedics | 537.0K | — | — | 1.98M | 344.4K | 361.8K | 3.22M | 61.42% | ↗ |
| 45 | 2021 | Patrick J. Beyer – President, CONMED International and Global Orthopedics | 537.0K | — | — | 1.98M | 344.4K | 361.8K | 3.22M | 61.42% | ↗ |
| 46 | 2021 | Patrick J. Beyer – President, CONMED International & Global Orthopedics | 537.0K | — | — | 1.98M | 344.4K | 361.8K | 3.22M | 61.42% | ↗ |
| 47 | 2021 | Todd W. Garner – Executive Vice President and Chief Financial Officer | 498.4K | — | — | 1.91M | 354.8K | 55.3K | 2.82M | 67.73% | ↗ |
| 48 | 2021 | Todd W. Garner – Executive Vice President, Finance and Chief Financial Officer | 498.4K | — | — | 1.91M | 354.8K | 55.3K | 2.82M | 67.73% | ↗ |
| 49 | 2021 | Stanley W. (Bill) Peters – President, Advanced Surgical & Advanced Endoscopic Technologies | 398.7K | — | — | 1.12M | 226.2K | 56.1K | 1.80M | 62.09% | ↗ |
| 50 | 2021 | Stanley W. (Bill) Peters – Vice President & General Manager, U.S. Advanced Surgical | 398.7K | — | — | 1.12M | 226.2K | 56.1K | 1.80M | 62.09% | ↗ |
| 51 | 2021 | Daniel S. Jonas – Executive Vice President, General Counsel & Secretary | 386.0K | — | — | 899.5K | 219.4K | 41.0K | 1.55M | 58.18% | ↗ |
| 52 | 2020 | Curt R. Hartman – Chair of the Board, President & Chief Executive Officer | 888.3K | — | — | 4.67M | 766.6K | 132.7K | 6.46M | 72.33% | ↗ |
| 53 | 2020 | Curt R. Hartman – Chair, President & Chief Executive Officer | 888.3K | — | — | 4.67M | 766.6K | 132.7K | 6.46M | 72.33% | ↗ |
| 54 | 2020 | Patrick J. Beyer – President, CONMED International and Global Orthopedics | 477.3K | — | — | 1.25M | 283.4K | 171.7K | 2.19M | 57.35% | ↗ |
| 55 | 2020 | Patrick J. Beyer – President, CONMED International & Global Orthopedics | 477.3K | — | — | 1.25M | 283.4K | 171.7K | 2.19M | 57.35% | ↗ |
| 56 | 2020 | Patrick J. Beyer – President, CONMED International | 477.3K | — | — | 1.25M | 283.4K | 171.7K | 2.19M | 57.35% | ↗ |
| 57 | 2020 | Todd W. Garner – Executive Vice President and Chief Financial Officer | 478.8K | — | — | 1.21M | 284.0K | 63.7K | 2.03M | 59.38% | ↗ |
| 58 | 2020 | Stanley W. (Bill) Peters – Vice President & General Manager, U.S. Advanced Surgical | 386.5K | — | — | 706.8K | 185.6K | 48.6K | 1.33M | 53.24% | ↗ |
| 59 | 2020 | John E. (Jed) Kennedy – Group Executive Vice President, Advanced Endoscopic Technologies | 358.2K | — | 488.5K | 216.6K | 171.1K | 43.6K | 1.28M | 55.17% | ↗ |
| 60 | 2019 | Curt R. Hartman – Chair, President & Chief Executive Officer | 842.5K | — | — | 4.14M | 1.07M | 135.9K | 6.18M | 66.92% | ↗ |
| 61 | 2019 | Curt R. Hartman – President & Chief Executive Officer | 842.5K | — | — | 4.14M | 1.07M | 135.9K | 6.18M | 66.92% | ↗ |
| 62 | 2019 | Todd W. Garner – Executive Vice President and Chief Financial Officer | 439.2K | 60.0K | 504.1K | 992.6K | 382.5K | 59.3K | 2.44M | 61.40% | ↗ |
| 63 | 2019 | Patrick J. Beyer – President, CONMED International and Global Orthopedics | 415.8K | 50.0K | — | 1.16M | 331.9K | 129.6K | 2.09M | 55.53% | ↗ |
| 64 | 2019 | Patrick J. Beyer – President, CONMED International | 415.8K | 50.0K | — | 1.16M | 331.9K | 129.6K | 2.09M | 55.53% | ↗ |
| 65 | 2019 | Stanley W. (Bill) Peters – Vice President & General Manager, U.S. Advanced Surgical | 371.8K | 35.0K | — | 661.8K | 243.4K | 208.4K | 1.52M | 43.52% | ↗ |
| 66 | 2019 | Nathan Folkert – Vice President & General Manager, U.S. Orthopedics | 371.5K | 25.0K | — | 661.8K | 202.3K | 28.2K | 1.29M | 51.35% | ↗ |
| 67 | 2018 | Curt R. Hartman – Chair, President & Chief Executive Officer | 790.9K | — | — | 2.62M | 1.08M | 102.4K | 4.59M | 57.01% | ↗ |
| 68 | 2018 | Curt R. Hartman – President & Chief Executive Officer | 790.9K | — | — | 2.62M | 1.08M | 102.4K | 4.59M | 57.01% | ↗ |
| 69 | 2018 | Todd W. Garner – Executive Vice President and Chief Financial Officer | 423.4K | — | 404.9K | 571.7K | 377.4K | 74.4K | 1.85M | 52.74% | ↗ |
| 70 | 2018 | Patrick J. Beyer – President, CONMED International | 384.7K | — | — | 852.7K | 273.6K | 115.2K | 1.63M | 52.44% | ↗ |
| 71 | 2018 | Stanley W. (Bill) Peters – Vice President & General Manager, U.S. Advanced Surgical | 359.2K | — | — | 478.7K | 266.6K | 112.1K | 1.22M | 39.35% | ↗ |
| 72 | 2018 | Nathan Folkert – Vice President & General Manager, U.S. Orthopedics | 362.8K | — | — | 523.6K | 241.5K | 24.1K | 1.15M | 45.45% | ↗ |
| 73 | 2017 | Curt R. Hartman – President & Chief Executive Officer | 753.2K | — | — | 1.60M | 555.0K | 91.5K | 3.00M | 53.38% | ↗ |
| 74 | 2017 | Patrick J. Beyer – President, CONMED International | 393.0K | 23.7K | — | 574.0K | 156.5K | 79.2K | 1.23M | 46.80% | ↗ |
| 75 | 2017 | Luke A. Pomilio – Executive Vice President, Finance | 398.8K | — | — | 483.4K | 196.6K | 99.4K | 1.18M | 41.03% | ↗ |
| 76 | 2017 | Nathan Folkert – Vice President & General Manager, U.S. Orthopedics | 356.4K | — | 67.1K | 362.5K | 111.2K | 22.4K | 919.6K | 46.72% | ↗ |
| 77 | 2017 | Stanley W. (Bill) Peters – Vice President & General Manager, U.S. Advanced Surgical | 355.7K | — | — | 332.3K | 110.8K | 39.7K | 838.5K | 39.63% | ↗ |
| 78 | 2016 | Curt R. Hartman – President & Chief Executive Officer | 710.0K | — | 358.8K | 1.48M | 506.2K | 37.8K | 3.09M | 59.42% | ↗ |
| 79 | 2016 | Luke A. Pomilio – Executive Vice President, Finance | 385.0K | — | 103.7K | 435.4K | 181.5K | 68.8K | 1.17M | 45.90% | ↗ |
| 80 | 2016 | Luke A. Pomilio – Executive Vice President, Finance & Chief Financial Officer | 385.0K | — | 103.7K | 435.4K | 181.5K | 68.8K | 1.17M | 45.90% | ↗ |
| 81 | 2016 | Patrick J. Beyer – President, CONMED International | 341.6K | — | 115.6K | 480.6K | 127.7K | 62.6K | 1.13M | 52.85% | ↗ |
| 82 | 2016 | Patrick J. Beyer –President, CONMED International | 341.6K | — | 115.6K | 480.6K | 127.7K | 62.6K | 1.13M | 52.85% | ↗ |
| 83 | 2016 | Nathan Folkert – Vice President & General Manager, U.S. Orthopedics | 352.8K | — | 79.7K | 330.2K | 128.6K | 115.6K | 1.01M | 40.71% | ↗ |
| 84 | 2016 | Stanley W. (Bill) Peters – Vice President & General Manager, U.S. Advanced Surgical | 341.6K | 8.6K | 67.8K | 284.2K | 127.7K | 43.1K | 873.0K | 40.32% | ↗ |
| 85 | 2015 | Curt R. Hartman – President & Chief Executive Officer | 724.3K | 213.0K | 4.16M | 1.69M | 106.5K | 70.9K | 6.96M | 83.98% | ↗ |
| 86 | 2015 | Curt R. Hartman – President | 724.3K | 213.0K | 4.16M | 1.69M | 106.5K | 70.9K | 6.96M | 83.98% | ↗ |
| 87 | 2015 | Luke A. Pomilio – Executive Vice President, Finance | 394.8K | 48.1K | 123.1K | 522.9K | 44.3K | 371.0K | 1.50M | 42.95% | ↗ |
| 88 | 2015 | Luke A. Pomilio – Executive Vice President, Finance & Chief Financial Officer | 394.8K | 48.1K | 123.1K | 522.9K | 44.3K | 371.0K | 1.50M | 42.95% | ↗ |
| 89 | 2015 | Mark D. Snyder – Executive Vice President, Operations & Business Systems | 310.8K | — | 396.7K | 380.0K | 75.0K | 300.9K | 1.46M | 53.08% | ↗ |
| 90 | 2015 | Patrick J. Beyer –President, CONMED International | 426.0K | 59.7K | 138.5K | 576.3K | 92.3K | 65.3K | 1.36M | 52.63% | ↗ |
| 91 | 2015 | Patrick J. Beyer – President, CONMED International | 426.0K | 59.7K | 138.5K | 576.3K | 92.3K | 65.3K | 1.36M | 52.63% | ↗ |
| 92 | 2015 | Patrick J. Beyer – President, International | 426.0K | 59.7K | 138.5K | 576.3K | 92.3K | 65.3K | 1.36M | 52.63% | ↗ |
| 93 | 2015 | Daniel S. Jonas – Executive Vice President, Legal Affairs | 326.8K | 24.0K | 210.3K | 281.9K | 79.9K | 338.3K | 1.26M | 39.03% | ↗ |
| 94 | 2015 | Robert D. Shallish, Jr. - Executive Vice President, Finance | 104.3K | — | — | — | — | 351.1K | 455.4K | 0.00% | ↗ |
| 95 | 2014 | Joseph J. Corasanti – Former President Chief Executive Officer | 360.4K | — | 2.76M | 1.59M | — | 6.45M | 11.28M | 38.56% | ↗ |
| 96 | 2014 | Robert D. Shallish, Jr. - Executive Vice President, Finance | 330.9K | — | 1.47M | 799.2K | 170.6K | 91.0K | 2.86M | 79.29% | ↗ |
| 97 | 2014 | Robert D. Shallish, Jr. - Executive Vice President, Finance Chief Financial Officer | 330.9K | — | 1.47M | 799.2K | 170.6K | 59.1K | 2.86M | 79.29% | ↗ |
| 98 | 2014 | Curt R. Hartman – President | 262.4K | — | 1.31M | — | 257.8K | 49.0K | 1.87M | 69.64% | ↗ |
| 99 | 2014 | Curt R. Hartman – President Chief Executive Officer | 262.4K | — | 1.31M | — | 257.8K | 49.0K | 1.87M | 69.64% | ↗ |
| 100 | 2014 | Curt R. Hartman – President & Chief Executive Officer | 262.4K | — | 1.31M | — | 257.8K | 49.0K | 1.87M | 69.64% | ↗ |
| 101 | 2014 | Luke A. Pomilio – Executive Vice President, Finance & Chief Financial Officer | 328.7K | — | 145.9K | 104.5K | 168.2K | 130.7K | 878.0K | 28.53% | ↗ |
| 102 | 2014 | Luke A. Pomilio - Executive Vice President, Controller and Corporate General Manager | 328.7K | — | 145.9K | 104.5K | 168.2K | 57.5K | 878.0K | 28.53% | ↗ |
| 103 | 2014 | Luke A. Pomilio – Executive Vice President, Finance | 328.7K | — | 145.9K | 104.5K | 168.2K | 130.7K | 878.0K | 28.53% | ↗ |
| 104 | 2014 | Joseph G. Darling – Executive Vice President, Commercial Operations | 381.9K | — | 116.7K | 87.1K | 197.6K | 28.4K | 819.2K | 24.89% | ↗ |
| 105 | 2014 | Daniel S. Jonas – Executive Vice President, Legal Affairs | 299.0K | — | 145.9K | 104.5K | 154.6K | 103.8K | 807.8K | 31.01% | ↗ |
| 106 | 2014 | Daniel S. Jonas – Executive Vice President, Legal Affairs General Counsel | 299.0K | — | 145.9K | 104.5K | 154.6K | 48.7K | 807.8K | 31.01% | ↗ |
| 107 | 2013 | Joseph J. Corasanti – Former President Chief Executive Officer | 805.9K | — | 823.3K | — | 405.4K | 184.1K | 2.93M | 28.12% | ↗ |
| 108 | 2013 | Luke A. Pomilio - Executive Vice President, Controller and Corporate General Manager | 316.9K | — | 331.8K | — | 164.0K | 51.6K | 981.5K | 33.81% | ↗ |
| 109 | 2013 | Luke A. Pomilio – Executive Vice President, Finance | 316.9K | — | 331.8K | 117.3K | 164.0K | 51.6K | 981.5K | 45.75% | ↗ |
| 110 | 2013 | Robert D. Shallish, Jr. - Executive Vice President, Finance | 320.8K | — | 230.5K | 146.6K | 166.3K | 61.5K | 925.6K | 40.74% | ↗ |
| 111 | 2013 | Robert D. Shallish, Jr. - Executive Vice President, Finance Chief Financial Officer | 320.8K | — | 230.5K | — | 166.3K | 61.5K | 925.6K | 24.90% | ↗ |
| 112 | 2013 | Joseph G. Darling – Executive Vice President, Commercial Operations | 371.9K | — | 131.7K | — | 192.6K | 49.1K | 843.0K | 15.63% | ↗ |
| 113 | 2013 | Daniel S. Jonas – Executive Vice President, Legal Affairs | 290.6K | — | 131.7K | 97.7K | 150.6K | 55.4K | 726.1K | 31.60% | ↗ |
| 114 | 2013 | Daniel S. Jonas – Executive Vice President, Legal Affairs General Counsel | 290.6K | — | 131.7K | — | 150.6K | 55.4K | 726.1K | 18.14% | ↗ |
| 115 | 2012 | Joseph J. Corasanti – Former President Chief Executive Officer | 764.2K | — | 652.3K | — | 441.2K | 185.6K | 2.66M | 24.55% | ↗ |
| 116 | 2012 | Joseph J. Corasanti - President Chief Executive Officer | 764.2K | — | 652.3K | 461.0K | 441.2K | 185.6K | 2.66M | 41.89% | ↗ |
| 117 | 2012 | Robert D. Shallish, Jr. - Executive Vice President, Finance Chief Financial Officer | 311.5K | — | 156.5K | — | 196.0K | 62.1K | 909.5K | 17.21% | ↗ |
| 118 | 2012 | Luke A. Pomilio - Executive Vice President, Controller and Corporate General Manager | 307.5K | — | 104.4K | — | 193.3K | 57.9K | 776.6K | 13.44% | ↗ |
| 119 | 2012 | Joseph G. Darling – Executive Vice President, Commercial Operations | 361.1K | — | 104.4K | — | 156.4K | 48.6K | 748.3K | 13.95% | ↗ |
| 120 | 2012 | Daniel S. Jonas – Executive Vice President, Legal Affairs General Counsel | 280.1K | — | 104.4K | — | 176.5K | 57.1K | 721.8K | 14.46% | ↗ |
| 121 | 2011 | Joseph J. Corasanti - President Chief Executive Officer | 725.0K | — | 690.8K | — | 410.2K | 166.2K | 2.79M | 24.79% | ↗ |
| 122 | 2011 | Joseph J. Corasanti, President, Chief Executive Officer | 725.0K | — | 690.8K | 651.8K | 410.2K | 166.2K | 2.79M | 48.19% | ↗ |
| 123 | 2011 | Joseph G. Darling– President CONMED Linvatec Vice President- Corporate Commercial Operations | 351.4K | — | 776.8K | — | 353.0K | 137.5K | 1.62M | 47.82% | ↗ |
| 124 | 2011 | Joseph G. Darling – Executive Vice President, Commercial Operations | 351.4K | — | 776.8K | — | 353.0K | 137.5K | 1.62M | 47.82% | ↗ |
| 125 | 2011 | Robert D. Shallish, Jr. - Executive Vice President, Finance Chief Financial Officer | 301.2K | — | 165.8K | — | 226.3K | 56.2K | 998.5K | 16.60% | ↗ |
| 126 | 2011 | Robert D. Shallish, Jr., Chief Financial Officer and Vice President- Finance | 301.2K | — | 165.8K | 146.0K | 226.3K | 56.2K | 998.5K | 31.23% | ↗ |
| 127 | 2011 | Luke A. Pomilio, Vice President, Controller Corporate General Manager | 293.4K | — | 240.5K | 104.3K | 221.0K | 50.5K | 964.5K | 35.75% | ↗ |
| 128 | 2011 | Luke A. Pomilio - Executive Vice President, Controller and Corporate General Manager | 293.4K | — | 240.5K | — | 221.0K | 50.5K | 964.5K | 24.94% | ↗ |
| 129 | 2011 | Daniel S. Jonas – General Counsel Vice President Legal Affairs | 267.8K | — | 110.5K | 104.3K | 201.1K | 63.9K | 788.9K | 27.23% | ↗ |
| 130 | 2011 | Daniel S. Jonas – Executive Vice President, Legal Affairs General Counsel | 267.8K | — | 110.5K | — | 201.1K | 63.9K | 788.9K | 14.01% | ↗ |
| 131 | 2010 | Joseph J. Corasanti, President, Chief Executive Officer | 699.8K | — | 481.5K | 482.4K | 345.3K | 128.6K | 2.22M | 43.48% | ↗ |
| 132 | 2010 | Joseph J. Corasanti - President Chief Executive Officer | 699.8K | — | 481.5K | — | 345.3K | 128.6K | 2.22M | 21.72% | ↗ |
| 133 | 2010 | Robert D. Shallish, Jr., Chief Financial Officer and Vice President- Finance | 282.8K | — | 115.6K | 108.0K | 190.5K | 36.3K | 791.3K | 28.26% | ↗ |
| 134 | 2010 | Robert D. Shallish, Jr. - Executive Vice President, Finance Chief Financial Officer | 282.8K | — | 115.6K | — | 190.5K | 36.3K | 791.3K | 14.60% | ↗ |
| 135 | 2010 | Joseph G. Darling– President CONMED Linvatec Vice President- Corporate Commercial Operations | 343.5K | 33.9K | 265.7K | — | — | 87.5K | 733.2K | 36.23% | ↗ |
| 136 | 2010 | Joseph G. Darling – Executive Vice President, Commercial Operations | 343.5K | 33.9K | 265.7K | — | — | 87.5K | 733.2K | 36.23% | ↗ |
| 137 | 2010 | Joseph G. Darling – President CONMED Linvatec | 343.5K | 33.9K | 265.7K | — | — | 87.5K | 733.2K | 36.23% | ↗ |
| 138 | 2010 | Luke A. Pomilio, Vice President, Controller Corporate General Manager | 274.7K | — | 77.0K | 77.2K | 180.9K | 36.2K | 668.4K | 23.07% | ↗ |
| 139 | 2010 | Luke A. Pomilio - Executive Vice President, Controller and Corporate General Manager | 274.7K | — | 77.0K | — | 180.9K | 36.2K | 668.4K | 11.53% | ↗ |
| 140 | 2010 | Daniel S. Jonas – General Counsel Vice President Legal Affairs | 253.3K | — | 77.0K | 77.2K | 169.3K | 45.6K | 639.3K | 24.12% | ↗ |
| 141 | 2010 | Daniel S. Jonas – General Counsel Vice President – Legal Affairs | 253.3K | — | 77.0K | 77.2K | 169.3K | 45.6K | 639.3K | 24.12% | ↗ |
| 142 | 2010 | Daniel S. Jonas – Executive Vice President, Legal Affairs General Counsel | 253.3K | — | 77.0K | — | 169.3K | 45.6K | 639.3K | 12.05% | ↗ |
| 143 | 2009 | Joseph J. Corasanti, President, Chief Executive Officer | 657.6K | — | 835.3K | 760.7K | — | 98.7K | 2.41M | 66.22% | ↗ |
| 144 | 2009 | Joseph G. Darling – President CONMED Linvatec | 324.7K | — | 65.8K | — | — | 84.2K | 543.1K | 12.12% | ↗ |
| 145 | 2009 | Joseph G. Darling– President CONMED Linvatec Vice President- Corporate Commercial Operations | 324.7K | — | 65.8K | 67.0K | — | 84.2K | 543.1K | 24.46% | ↗ |
| 146 | 2009 | Robert D. Shallish, Jr., Chief Financial Officer and Vice President- Finance | 264.7K | — | 65.8K | 67.0K | — | 29.1K | 462.3K | 28.74% | ↗ |
| 147 | 2009 | Luke A. Pomilio, Vice President, Controller Corporate General Manager | 254.0K | — | 65.8K | 67.0K | — | 31.2K | 427.9K | 31.05% | ↗ |
| 148 | 2009 | Luke A. Pomilio, Vice President – Corporate Controller | 254.0K | — | 65.8K | 67.0K | — | 31.2K | 427.9K | 31.05% | ↗ |
| 149 | 2009 | David A. Johnson – VP, Global Operations Supply Chain | 254.0K | — | 65.8K | 67.0K | — | 35.0K | 423.5K | 31.37% | ↗ |
| 150 | 2009 | Daniel S. Jonas – General Counsel Vice President Legal Affairs | 239.7K | — | 65.8K | 67.0K | — | 40.8K | 420.7K | 31.58% | ↗ |
| 151 | 2009 | Daniel S. Jonas – General Counsel Vice President – Legal Affairs | 239.7K | — | 65.8K | — | — | 40.8K | 420.7K | 15.65% | ↗ |
| 152 | 2008 | Joseph J. Corasanti, President, Chief Executive Officer | 641.4K | — | 667.3K | — | 225.4K | 92.0K | 2.30M | 29.00% | ↗ |
| 153 | 2008 | Robert D. Shallish, Jr., Chief Financial Officer and Vice President- Finance | 256.6K | — | 106.8K | — | 117.6K | 22.4K | 685.0K | 15.59% | ↗ |
| 154 | 2008 | Luke A. Pomilio, Vice President, Controller Corporate General Manager | 232.0K | — | 106.8K | — | 106.0K | 22.3K | 592.0K | 18.03% | ↗ |
| 155 | 2008 | Daniel S. Jonas – General Counsel Vice President – Legal Affairs | 232.4K | — | 52.4K | — | 106.4K | 28.6K | 579.2K | 9.04% | ↗ |
| 156 | 2008 | Daniel S. Jonas, General Counsel Vice President – Legal Affairs | 232.4K | — | 52.4K | 134.7K | 106.4K | 28.6K | 579.2K | 32.30% | ↗ |
| 157 | 2008 | Luke A. Pomilio, Vice President – Corporate Controller | 232.0K | — | 52.4K | 134.7K | 106.0K | 22.3K | 578.1K | 32.36% | ↗ |
| 158 | 2008 | David A. Johnson – VP, Global Operations Supply Chain | 229.5K | — | 47.4K | 46.0K | 105.9K | 18.0K | 456.3K | 20.47% | ↗ |
| 159 | 2007 | Joseph J. Corasanti, Chief Executive Officer | 464.1K | — | 193.1K | 353.9K | 330.8K | 80.5K | 1.46M | 37.37% | ↗ |
| 160 | 2007 | Joseph J. Corasanti, President, Chief Executive Officer | 464.1K | — | 193.1K | — | 330.8K | 80.5K | 1.46M | 13.19% | ↗ |
| 161 | 2007 | Gerald G. Woodard, President – CONMED Linvatec | 290.4K | — | 15.5K | 86.5K | 207.7K | 21.0K | 646.0K | 15.78% | ↗ |
| 162 | 2007 | Robert D. Shallish, Jr., Chief Financial Officer and Vice President- Finance | 243.1K | — | 30.9K | — | 172.5K | 21.2K | 633.1K | 4.88% | ↗ |
| 163 | 2007 | Daniel S. Jonas, General Counsel Vice President – Legal Affairs | 220.1K | — | 30.9K | — | 156.2K | 35.3K | 592.2K | 5.22% | ↗ |
| 164 | 2007 | Luke A. Pomilio, Vice President – Corporate Controller | 218.7K | — | 30.9K | — | 155.6K | 17.3K | 566.9K | 5.45% | ↗ |
| 165 | 2006 | Eugene R. Corasanti, Chief Executive Officer | 461.8K | — | 62.6K | 70.0K | 304.5K | 42.3K | 1.16M | 11.43% | ↗ |
| 166 | 2006 | Joseph J. Corasanti, President, Chief Executive Officer | 408.3K | — | 62.6K | — | 268.7K | 83.8K | 1.09M | 5.75% | ↗ |
| 167 | 2006 | Joseph J. Corasanti, President Chief Operating Officer | 408.3K | — | 62.6K | 219.9K | 268.7K | 83.8K | 1.09M | 25.96% | ↗ |
| 168 | 2006 | Robert D. Shallish, Jr., Chief Financial Officer and Vice President- Finance | 232.4K | — | 10.0K | — | 152.6K | 22.4K | 612.8K | 1.64% | ↗ |
| 169 | 2006 | David R. Murray, President - CONMED Electrosurgery | 266.0K | — | 5.0K | 74.4K | 189.4K | 13.8K | 572.3K | 13.87% | ↗ |
| 170 | 2006 | Daniel S. Jonas, General Counsel Vice President – Legal Affairs | 210.5K | — | 10.0K | — | 138.1K | 20.7K | 543.6K | 1.84% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Patrick J. Beyer | President, Chief Executive Officer & Director | 3M | male |
| Curt R. Hartman | Special Advisor | 2M | male |
| Todd W. Garner | Advisor | 1M | male |
| Hollie Foust | Executive Vice President, General Counsel and Corporate Secretary | 842.8K | female |
| Brent Lalomia | Executive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations & IT | 787.8K | male |
| Peter K. Shagory | Executive Vice President of Strategy & Corporate Development | 713.8K | male |
| David R. Murray | President of ConMed Electrosurgery | 469.2K | male |
| Johonna Marie Pelletier | Vice President of Tax & Treasurer | — | female |
| John Ferrell | Executive Vice President of Human Resources | — | male |
| Andrew Moller | Interim Principal Financial Officer, Principal Accounting Officer, VP & Corporate Controller | — | male |
| Josep Lluis Llorens | Executive VP Global Supply Chain Management & Operations | — | male |
| Keith Seaton | Vice President of Compliance | — | — |
No Senate trading activity found for this company.
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2019-02-15 | 2019-03-14 | Van Taylor | TX03 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CNMD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
